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 Abstract.
This thesis describes the work that was done to investigate the use of L. plantarum 
WCFS1 as a live delivery vehicle for the delivery of the M. tuberculosis fusion antigen 
TB10.4-HspX (TH) that is C-terminal fused with a dendritic cell binding peptide (DC-seq). 
The fusion antigen TH has been shown to elicit immune response from tuberculosis 
patients with active and latent tuberculosis infection, making the fusion antigen a promising 
candidate as a multistage vaccine against tuberculosis. The coupling to the DC-seq may 
enhance the immune response by potentially increasing uptake by dendritic cells. Lactic 
acid bacteria (LAB) are commonly used in food production, abundant in the environment 
and are a natural inhabitant in the human gastro-intestinal tract (GIT). These characteristics 
and their status as “generally regarded as safe” (GRAS), make LAB attractive candidates as 
oral delivery vehicles for biomolecules to mucosal sites. L. plantarum WCFS’s ability to 
survive passage through stomach and in the GIT for more than six days in its active form, 
make this bacterium well suited as an oral delivery vehicle. 
Two non-GM approaches and one GM approach have been conducted in this study. In 
the non-GM approaches, TH_DC-seq and TH_DC-seq fused to a peptidoglycan binding 
LysM-anchor was produced intracellularly in E. coli or in L. plantarum WCFS1 with 
subsequent extraction and binding to wild type L. plantarum WCFS1. Getting adequate 
amounts of soluble fusion proteins for purification turned out to be challenging and thus, 
binding assays were done using the soluble fraction since no purified extracts were 
obtained. Both LysM_TH_DC-seq and TH_DC-seq seemed to be able to bind to L. 
plantarum WCFS1.  
In the GM approach, TH_DC-seq was constructed for direct display on the cell surface 
of recombinant L. plantarum WCFS1 using three different anchors (LysM-anchor, LPxTG-
anchor and lipobox-anchor). Production was confirmed except in the case of TH_DC-seq 
that was coupled to the LPxTG-anchor. Correct anchoring could not be confirmed, as 
fusion proteins on the cell surface of live cells could not be detected.  
In conclusion, this study shows that production of TH_DC-seq is possible in both E. 
coli and L. plantarum WCFS1. Binding assays indicate that using L. plantarum WCFS1 as 
delivery vehicle for TH_DC-seq is a promising strategy for development of a novel vaccine 
against tuberculosis. 
Sammendrag.
Oppgaven omhandler forsøk gjort for å undersøke bruk av L. Plantarum WCFS1 som 
levende vektor for levering av M. tuberculosis fusjonsantigenet TB10.4-HspX (TH) som er C-
terminalt fusert til et peptid (DC-seq) med affinitet for dendrittiske celler. Det er blitt vist at 
fusjonsantigenet TH kan initiere immunrespons hos tuberkulosepasienter med aktiv eller latent 
infeksjon, noe som gjøre TH til en lovende kandidat for utvikling av en multifasevaksine mot 
tuberkulose. Fusering til DC-seq kan forsterke immunresponsen ved å potensielt øke opptak av 
fusjonsantigenet av dendrittiske celler. Melkesyrebakterier er ofte brukt i matproduksjon, vanlig å 
finne i miljøet og er en del av den naturlige floraen i det humane fordøyelsessystemet. Disse 
karaktertrekkene og deres status som ”generally regarded as safe” (GRAS), gjør 
melkesyrebakteriene til gode kandidater som leveringsvektorer for oral levering av biomolekyler via 
slimhinner. L. Plantarum WCFS1 er velegnet som en oral leveringsvektor fordi bakterien kan 
overleve passeringen forbi magesekken og i mer enn seks dager i mage-tarm-kanalen. 
To ikke-genmodifiserte tilnærminger og én genmodifisert tilnærming har blitt utført i dette 
prosjektet. I de ikke-genmodifiserte tilnærmingene ble TH_DC-seq og TH_DC-seq fusert til et 
peptidoglykanbindene LysM-anker, produsert i E. coli  eller L. plantarum WCFS1. Produseringen 
etterfølges av proteinekstraksjon og bindingsekperiment til villtype L. plantarum WCFS1. Å få 
tilstrekkelig mengde av løselig fusjonsprotein til rensing viste seg å være vanskelig, dermed ble 
bindingsstudiene utført med den løselige fraksjonen ettersom ingen renset ekstrakt kunne anskaffes. 
Både LysM_TH_DC-seq og TH_DC-seq synes å kunne binde seg til L. plantarum WCFS1.  
I den genmodifiserte tilnærmingen ble TH_DC-seq konstruert til å bli direkte forankret på 
celleoverflaten til rekombinant L. plantarum WCFS1 ved hjelp av tre ulike anker (et LysM-anker, et 
LPxTG-anker og et lipoboks-anker). Produksjon av disse fusjonsproteinene var bekreftet, med 
unntak av TH_DC-seq som var fusert med LPxTG-ankeret. Riktig forankring på celleoverflaten 
kunne ikke bli bekreftet da fusjonsproteinene kunne ikke bli detektert på celleoverflaten av levende 
celler.  
I konklusjon kan man med arbeidet gjort i dette prosjektet vise at det er mulig å produsere 
TH_DC-seq med både E. coli og L. plantarum WCFS1. Bindingsstudiene viser at bruk av L. 
plantarum WCFS1 som leveringsvektor av TH_DC-seq er en lovende strategi for utvikling av en ny 
tuberkulosevaksine. 
 .
Abbreviations.
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DC-seq Peptide sequence that shows affinity for dendritic cells 
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1 Introduction.
With increasing emergence of resistant tuberculosis (TB) infections and the suboptimal 
effective BCG (Bacillus Calmette–Guérin) vaccine as the only available clinical vaccine, 
there is a worldwide need for new effective vaccines and therapies against TB infections 
(Tortora, Funke, & Case, 2010; WHO | Global tuberculosis report 2014, 2014). In this 
respect, oral vaccination is of interest since it can offer a simpler administration and 
avoidance of risks associated with systemic vaccination, as well as the potential to induce 
mucosal immune response (Lavelle & O’Hagan, 2006).  
This thesis describes work aimed at attaching Mycobacterium tuberculosis antigens to 
the surface of Lactobacillus plantarum WFCS1, a food grade lactic acid bacteria, as a 
delivery vehicle in an oral vaccine against TB. 
1.1 Tuberculosis..
The obligate aerobe bacillus M. tuberculosis causes tuberculosis (TB), an airborne 
infectious disease that mainly affects the respiratory system (pulmonary TB). In the lung, 
M. tuberculosis primary invades alveolar macrophages, but can also be taken up by local 
dendritic cells (DCs) (Ottenhoff & Kaufmann, 2012; Tortora et al., 2010). M. tuberculosis 
can delay priming of T-cell responses in the local draining lymph nodes of the lungs by at 
least 1-2 weeks. This gives time to build up a critical mass of the bacilli that can develop 
into two types of population: latent, non-replicating cells that present a potential reservoir 
(latent infection); and metabolically active and replicating bacteria that stimulate immune 
response that give protection or cause TB pathology (active infection). 
Worldwide, TB is the second leading cause of death of infectious diseases, and the 
African Region has the highest rate of new cases and deaths relative to population (WHO | 
Global tuberculosis report 2014, 2014). It has been estimated by the World Health 
Organization (WHO) that 2013 brought 9 millions new cases of TB and 1.5 millions TB 
deaths, and that about one in every four of the TB deaths was HIV positive. Although a 
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relatively small proportion of people infected with M. tuberculosis will develop TB, the 
incidence rate is much higher for HIV positive people. Given that most TB deaths are 
preventable with diagnosis and treatment, WHO states that the current TB mortality is 
unacceptably high.  
With a slow generation time of 20 hours and a tendency to develop latent infections, 
treatment for pulmonary TB lasts for a minimum of six months (Tortora et al., 2010). 
WHO’s recommended standard regimen for new pulmonary TB cases lasts for six months 
and consists of two fixed-dose combinations of antibiotics, both containing rifampicin 
(WHO | Guidelines for treatment of tuberculosis, 2010). The long run of treatment often 
causes compliance problems and may therefore contribute to development of antibiotic 
resistance. For 2013, global estimation of multidrug-resistant TB (MDR-TB) among new 
TB cases and retreatments were 3.5% and 20.5%, respectively (WHO | Global tuberculosis 
report 2014, 2014). This trend has remained unchanged between 2008 and 2013, but the 
gap between the number of diagnosis and the number of treatment seems to have widened 
from 2012 to 2013. Countries such as Russia and other eastern European countries are 
experiencing serious epidemics of MDR-TB (figure 1.1 and figure 1.2). The “End TB 
Strategy” approved by WHO in May 2014, aims to reduce TB deaths by 95% and TB 
incidence by 90% by 2035 compared to 2015.  
 
  INTRODUCTION 
 
 3 
 
Figure 1.1 Percentage of new TB cases with MDR-TB(This figure was taken from WHO | Global tuberculosis report 
2014, 2014) 
 
 
 
 
Figure 1.2 Percentage of TB retreatment with MDR-TB (This figure was taken from WHO | Global tuberculosis 
report 2014, 2014) 
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1.2 The.antigens.from.M.#tuberculosis.as.vaccine.candidates.used.in.this.study.
In the search for antigens to be used in vaccines, many M. tuberculosis proteins have 
been evaluated and over a dozen are in clinical trials (Andersen & Woodworth, 2014; 
Ottenhoff & Kaufmann, 2012). In the present study, we have focused on a fusion protein 
consisting of TB10.4 and HspX antigens. Studies indicates that these antigens might play 
important roles in mycobacterium-specific functions such as intracellular survival and 
virulence (Skjøt et al., 2000, 2002; Yuan et al., 1998). A vaccine study that utilised fusion 
antigens of TB10.4 and HspX showed that the vaccine induces immune response in human 
T cells from both latent and active TB patients, showing potential as a good candidate for a 
multistage tuberculosis vaccine (Niu et al., 2011). 
The protein TB10.4 (10kDa) is a low-mass M. tuberculosis protein identified from 
culture filtrates and belong to a family of low-mass proteins (14-23 kDa) encoded by the 
esat6 gene family (Skjøt et al., 2000, 2002). TB10.4 can be further categorized to the 
TB10.4 sub-family consisting of TB10.3 (10kDa), TB10.4 (10kDa) and TB12.9 (13kDa). 
TB10.4 that has been used in this study, is produced in the virulent strain M. tuberculosis 
H37Rv but not in the avirulent strain M. tuberculosis H37Ra, suggesting its importance for 
M. tuberculosis virulence (Rindi, Lari, & Garzelli, 1999). TB10.4 contains several strong 
T-cell epitopes throughout the peptide sequence, with the dominant one in the N-terminus 
(amino acids 1-18). Epitope mapping of TB10.4 has shown that patients with active 
infection recognize a broader panel of epitopes than BCG vaccinated donors (Skjøt et al., 
2002).  
HspX or (also named Acr1) is a 16 kDa heat shock protein that is highly expressed in 
M. tuberculosis during hypoxic condition and latency (Siddiqui, Amir, & Agrewala, 2011). 
It is an ATP-independent chaperone that prevents aggregation of denatured protein and 
consequently also assists in the refolding process by other chaperones. Direct correlation 
has been observed between the rate of depletion of HspX and loss of tolerance to 
anaerobiosis (Wayne & Lin, 1982). Acr1 is the gene coding for HspX and activation of acr-
promoter is rapidly induced in vivo on entry to macrophage and in vitro under oxygen 
limitation (Yuan et al., 1998). Overexpression of HspX in exponential phase in vitro slows 
the growth rate of M. tuberculosis as well as the post-stationary phase autolysis in aging 
culture, indicating that synthesis of HspX comes at the expense of growth (Hu, 
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Movahedzadeh, Stoker, & Coates, 2006; Yuan et al., 1998). The needed hypoxic condition 
to induce HspX expression seems unlikely to cause protein instability and suggest that 
hypoxia may serve as a signal for hostile environment and expression of HspX may play a 
protective role for stress factors other than hypoxia (Yuan et al., 1998). The 
immunostimulatory effect of HspX lies in the N-terminus of the protein and mainly induces 
Th1 response (detection of IFN-γ release) (Siddiqui et al., 2011). It has also been shown 
that recombinant BCG overexpressing HspX increases efficacy of BCG and survival of 
immunocompromised mice, showing potential as candidate for a vaccine that boost 
protection against TB (Shi et al., 2010).  
 
1.3 Lactic.acid.bacteria.
Lactic acid bacteria (LAB) is a group of Gram-positive, anaerobic or microaerophilic 
cocci or bacilli (Berlec, Ravnikar, & Štrukelj, 2012; Chapot-Chartier & Kulakauskas, 
2014). Phylogenetically related genera are Carnobacterium, Enterococcus, Lactobacillus, 
Lactococcus, Leuconostoc, Oenococcus, Pediococcus, Streptococcus, Tetragenococcus, 
Vagococcus and Weisela. One of their shared features is the production of lactic acid as a 
product of carbohydrate metabolism. LAB is widely used in fermentation of food and they 
are nutritionally demanding and auxotrophic for several amino acids and nutrients. Thus, 
they easily colonize nutrient rich environments like meat, dairy products, plant 
fermentations, oral cavity, genital tracts and mammalian gastrointestinal tract (GIT). 
LAB is recognized as suitable vector candidates for oral delivery of biomolecules to 
mucosal surfaces for several reasons. Food and Drug Administration (FDA) has defined 
LAB as GRAS (generally regarded as safe) and some of the Lactobacilli species are 
considered as probiotic (Berlec et al., 2012; Chapot-Chartier & Kulakauskas, 2014). 
Probiotics are defined as “live microorganisms which, when consumed in adequate 
amounts as part of food, confer a health benefit on the host”. LAB is able to provoke or 
modulate an adaptive immune response as well as a tolerogenic one. L. plantarum has for 
example been studied to deliver antigens to the GIT. To avoid use of genetically modified 
(GM) bacteria, proteins can be fused with cell wall binding domains (CWBDs) and then 
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anchored to the LAB surface. This approach has been exploited with LysM- and SLH-
domains (LysM = Lys motif; SLH = S-layer homologous) to develop oral vaccines.  
1.3.1 Lactobacillus.plantarum.WCFS1.
The ability of L. plantarum to survive in human GIT has stimulated research in 
using the species as delivery vehicle for therapeutic compounds and vaccines (Berlec et al., 
2012; Kleerebezem et al., 2003). L. plantarum WCFS1 has become one of the model strains 
for LAB research since its first publication of its genome by Kleerebezem et al. (2003), 
followed by reseqencing and reannotations by Siezen et al. (2012) (Kleerebezem et al., 
2003; Siezen et al., 2012). L. plantarum WCFS1 was isolated from a single colony of L. 
plantarum NCIMB8826 originating from human saliva (Kleerebezem et al., 2003). It has 
been shown that this strain can survive passage through stomach in an active form and is 
able to persist for more than six days in the human GIT. Over 240 putative extracellular 
proteins have been predicted from the genome sequence and several proteins are predicted 
as cell-surface proteins. The predicted surface anchors include N- or C-terminal 
transmembrane anchors, lipoprotein anchors, LPxTG-anchors and other cell wall binding 
domains like LysM (see below).  
A study exploring the human intestinal response to L. plantarum WCFS1 has shown 
that this strain can induce time-dependent transcriptional changes in intestinal mucosa of 
healthy humans, and gene expression profile analysis indicates that this strain can trigger 
pro-inflammatory responses (Troost et al., 2008). Healthy participants that have been 
exposed to L. plantarum WCFS1 for six hours showed an overall upregulation of genes 
involved in cell growth, proliferation and development (Troost et al., 2008).  
1.4 Anchoring.motives.from.cell.surface.proteins.used.in.this.study.
Analysis of 13 genomes of lactobacilli, including L. plantarum WCFS1 has revealed 
that these species contain genes encoding for 4 of 7 known secretion pathways in Gram-
positive bacteria, namely secretion (Sec), fimbrilin-protein exporter (FPE), peptide efflux 
ABC and holin systems (Kleerebezem et al., 2010). Sec pathway is the major secretion 
pathway in Gram-positive bacteria and surface anchors used in this study are all derived 
from putative extracellular proteins that are subject to Sec secretion in L. plantarum WCS1. 
The Sec translocase consists of a membrane-embedded protein-conducting channel 
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(SecYEG) and an ATPase motor protein (SecA). All proteins secreted through Sec pathway 
contain a N-terminal signal peptide (SP). The SP typically consists of three regions – N, H 
and C. The N-region is a positively charged N-terminus, the H-region is a stretch of 15-25 
hydrophobic residues and the C-region is the C-terminus that may contain a cleavage site 
for Type-I or Type-II signal peptidase (SPase).  
Surface-associated proteins of Lactobacillus can be divide into four subcategories 
according to their anchoring mechanisms (Figure 1.3): (1) single hydrophobic N- or C-
terminal domain in transmembrane anchors that integrates into the cytoplasmic membrane 
(CM); (2) lipoproteins that are N-terminally anchored to long-chain fatty acids of the CM; 
(3) Covalent binding to peptidoglycan (PG) layer through a C-terminal LPxTG-motif; and 
(4) non-covalent binding to cell wall using various cell wall binding domains (Boekhorst, 
Wels, Kleerebezem, & Siezen, 2006; Kleerebezem et al., 2010).  
Boekhorst et al. (2006) repredicted 223 extracellular proteins (Figure 1.3) in L. 
plantarum WCFS1 (Boekhorst et al., 2006). A large majority of these are predicted to 
contain motives associated with cell surface anchoring: 48 contain a N-terminal lipobox 
that covalently attach Cys residue to a lipid in CM; 27 contain C-terminal LPxTG motif 
covalently attached to PG by sortase; 10 proteins contain one or more LysM domain; 71 
proteins contain N-terminal transmembrane anchors; 10 proteins contain C-terminal 
transmembrane anchors. Only 57 were predicted to be secreted proteins.  
 
Figure 1.3 Extracellular proteins of L. plantarum This picture shows various types of extracellular proteins from L. 
plantarum WCFS1 predicted by Boekhorst et al. 2006. Numbers in parentheses indicates the number of each type of the 
proteins predicted. (This figure was taken from Boekhorst et al. 2006) 
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1.4.1 Lysine.motif.–.anchoring.of.cell.surface.proteins.
The lysine motif (LysM) is thought to have a general PG-binding function and can 
be found in many extracellular proteins that are involved in cell-wall metabolism 
(Kleerebezem et al., 2010; Visweswaran, Leenhouts, van Roosmalen, Kok, & Buist, 2014). 
Prediction analysis of L. plantarum WCFS1 secretome by Boekhorst et al. (2006) has 
shown that predicted proteins with LysM domains also contain enzymatic domains with 
functions that are related to biosynthesis and degradation of polysaccharides (Boekhorst et 
al., 2006). This indicates that different enzymes employ a common method for anchoring to 
the PG.  
One copy of LysM typically contains 44-65 amino acid residues. Sequences from 
over 4,500 species from prokaryotes, eukaryotes and viruses have been registered in the 
Pfam database (www.pfam.org; entryPF01476). LysM is usually found in the N- or C-
terminus, and multiple LysM sequences are often separated by small linker sequences that 
are Ser-, Thr and Asn-rich (Visweswaran et al., 2014). Binding to PG occurs relatively fast 
and with high affinity (Andre, Leenhouts, Hols, & Dufrêne, 2008). LysM has specificity 
towards oligomers of N-acetylglucosamine (GlcNAc) (Ohnuma, Onaga, Murata, Taira, & 
Katoh, 2008; Visweswaran et al., 2014). Mesnage et al. (2014) showed that LysM-domain 
primary recognizes GlcNAc-X-GlcNAc (X=GlcNAc or MurNAc, MurNAc = N-
acetylmuramic acid) (Mesnage et al., 2014). Fusion proteins with LysM domains can thus 
be isolated through binding to PG or other N-acetylglucosamine containing glycans. This 
property of LysM has been utilized to display proteins on cell surfaces, by either direct 
display in expression host cell or through binding extracted LysM-containing proteins to 
non-GM cells.  
The LysM domains that are used in this study are derived from the genes lp_3014 
and lp_2162 of from L. plantarum WCFS1 (figure 1.4) (Zhou, Theunissen, Wels, & Siezen, 
2010). Lp_3014 is a putative extracellular transglycosylase containing one copy of N-
terminal LysM. Lp_2162 is a putative gamma-D-glutamate-meso-diaminoimelate 
muropeptidase with two copies of N-terminal LysM.  
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Figure 1.4 Predicted L. plantarum proteins with LysM domains (This figure was taken from Boekhorst et al. 2006) 
 
1.4.2 LPxTG.–.anchoring.of.cell.surface.proteins.
LPxTG-anchored proteins contain a C-terminal LPxTG motif and are anchored 
covalently to PG in a reaction catalysed by sortase (SrtA) (Boekhorst, de Been, 
Kleerebezem, & Siezen, 2005). These proteins typically contain a N-terminal SP with 
Type-I SPase cleavage site and the LPxTG motif at the C-terminus. After secretion, SrtA 
cleaves the LPxTG motif between T and G and covalently attaches the threonine carboxyl 
group to the PG. 
The LPxTG motif that is used in this study are derived from the gene lp_2578 that 
encodes a collagen-binding adherence protein from L. plantarum WCFS1(Zhou et al., 
2010).  
1.4.3 Lipobox.–.anchoring.of.cell.surface.proteins.
Lipoproteins are the second largest group of cell-surface associated proteins of 
Lactobacillus. These proteins contain the N-terminal lipobox motif L-(A/S)-(A/G)-C 
(Hutchings, Palmer, Harrington, & Sutcliffe, 2009; Kleerebezem et al., 2010). The Cys 
residue undergoes lipidation by lipoprotein diacylglyceryl transferase, generating a 
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thioether linkage. After that, Type-II SPase cleaves between the (Ala-/Gly-) and Cys-
residue and covalently anchors the mature protein to a lipid in the cytoplasmic membrane. 
The lipobox motif that is used in this study is derived from the gene lp_1261 that 
encodes for a substrate binding oligopeptide ABC transporter from L. plantarum WCFS1 
(Zhou et al., 2010). 
1.5 Peptide.sequences.with.affinity.for.dendritic.cells.
Dendritic cells (DCs) have the ability to induce and direct adaptive immune 
responses and tolerance (Merad, Sathe, Helft, Miller, & Mortha, 2013), thus the extent of a 
vaccine’s interaction with DCs may affect the efficacy of the vaccine. Classical DCs 
(cDCs) form a small group of tissue hematopoietic cells and reside in most lymphoid and 
non-lymphoid tissues. They have the ability to sense tissue injuries and present 
phagocytized antigens to T-cells. cDCs are further divided into different subsets that 
differently regulate T-cell responses. It is now known that DCs arise from a distinct 
hematopoietic lineage and transcriptome analysis suggests that cDC form a transcriptional 
entity that is distinct from other leukocytes.  
Antigens delivered by LAB are too large to enter systemic circulation through 
epithelial absorption in the GIT (Berlec et al., 2012). Instead, they are sampled by DCs that 
extrudes in-between intestinal epithelial cells and M-cells on Peyer’s patches in the small 
intestine of the GIT. Through sampling by DCs, antigens are presented to basal immune 
cells and can elicit local and distal immune responses, as well as systemic immune 
responses (Berlec et al., 2012; Purchiaroni et al., 2013).  
Curiel et al. (2004) have shown that specific peptide sequence with affinity for 
human DC could be coupled to hepatitis C virus antigen and that this enhances the immune 
response. The team screened a phage display peptide library of 12-mer peptide sequences 
with high affinity for human DCs. A 12-mer peptide sequence (FYPSYHSTPQRP; 
abbreviated as DC-seq) from the Curiel et al. (2004) study, which has previously shown 
successful for DC targeting when used in lactobacilli (Fredriksen, Mathiesen, Sioud, & 
Eijsink, 2010; Mohamadzadeh, Duong, Sandwick, Hoover, & Klaenhammer, 2009), has 
been used in this study to promote the immune response to antigens presented by 
lactobacilli to DCs.  
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1.6 Outline.of.this.study.
This study is a sub-project of an on-going main project in the Protein Engineering 
and Proteomics (PEP) group at NMBU, where the goal is to develop oral vaccines using 
LAB as delivery vehicle. The main objective of this study is to contribute to the 
development of a better tuberculosis vaccine that is more effective and convenient than the 
BCG vaccine.  
The main strategy explored in this study was to produce fusion proteins consisting of 
a LysM-anchor, the fused M. tuberculosis antigens TB10.4 and HspX (TH), and a DC-
binding sequence (DC-seq) and bind the fusion proteins to PG-layer of L. plantarum 
WCFS1 for the purpose of developing a non-GM oral vaccine. The experimental work done 
in this study can be divided into three main steps: (1) construction and intracellular 
expression of fusion proteins consisting of LysM, TH and DC-seq in E. coli and L. 
plantarum WCFS1; (2) purification of fusion proteins; (3) investigate binding efficacy of 
LysM-containing fusion proteins to wild type L. plantarum WFCS1.  
Due to challenging problems with intracellular production and purification using the 
commercial pET system (Novagen, 2011) and pSIP system (Sørvig et al., 2003), an 
alternative strategy based on generation of GM strains for delivery of antigens has also 
been commenced. In this side-study, TH and DC-seq has been fused with anchors and 
expressed in L. plantarum WCFS1 using the pSIP system. In this way, the antigens are 
hopefully displayed on cell surface of L. plantarum WFCS1. The anchors used in this side-
study were a lipobox-anchor, a LPxTG-anchor and a LysM-anchor.  
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2 Materials.
For a list of materials not described in the tables below, see appendix A. 
2.1 Bacterial.strains.and.plasmid.constructs.
Table 2.1 Bacterial strains 
 
 
Table 2.2 Vector systems 
Expression vector system Description Source 
   
pET-16b N-terminal His-tag 
Restriction sites for cloning: SalI 
and XhoI 
Genscript 
pLp Restriction sites for cloning: NdeI, 
SalI and EcoRI 
Derivative of the pSIP system 
from pSIP400-series (Sørvig et al., 
2003) 
pUC Restriction sites for cloning: SalI 
and EcoRI 
Merck 
 
 
 
 
 
 
 Source 
Escherichia coli strains:  
One Shot® BL21 Star™ (DE3)  
E.coli TOP10 
Stellar™ Competent Cells 
Invitrogen™ 
Invitrogen™ 
Clontech Laboratories 
Lactobacillus plantarum strains:  
L. plantarum WCFS1 
L. sakei Lb790 
L. rhamnosus GG 
Kleerebezem et.al. 2003 
Sørvig et.al. 2003 
ATCC 53103 
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Table 2.3 Plasmid constructed in this study 
Plasmid Constructed in this Study Description 
  
pET16b_2162S_TH_ DC-seq pET-16b plasmid that expresses a fusion protein consisting of 
2162S-LysM (has two N-terminal LysM domains from lp_2162), 
TH (M. tuberculosis fusion antigens used in this study) and DC-seq 
(the sequence that has affinity for DC). 
Designed for intracellular protein production and do not contain 
signal peptide. 
pET16b_2162S_TH pET-16b plasmid that expresses a fusion protein consisting of 2162S 
and TH. 
Designed for intracellular protein production and do not contain 
signal peptide. 
pET16b_3014_TH_ DC-seq pET-16b plasmid that expresses a fusion protein consisting of 3014 
(full-length sequence of lp_3014 that has one N-terminal LysM 
domains and the transglycosylase sequence), TH and DC-seq. 
Designed for intracellular protein production and do not contain 
signal peptide. 
pET16b_3014S_TH_ DC-seq pET-16b plasmid that expresses a fusion protein consisting of 3014S 
(truncated sequence of lp_3014 that only includes one copy of N-
terminal LysM domains), TH and DC-seq. 
Designed for intracellular protein production and do not contain 
signal peptide. 
pET16b_3014S_TH pET-16b plasmid that expresses a fusion protein consisting of 3014S 
and TH.  
Designed for intracellular protein production and do not contain 
signal peptide. 
pET16b_TH_DC-seq pET-16b plasmid that expresses a fusion protein consisting of TH 
and DC-seq. 
Designed for intracellular protein production and do not contain 
signal peptide. 
pET16b_TH pET-16b plasmid that expresses a fusion protein consisting of TH. 
Designed for intracellular protein production and do not contain 
signal peptide. 
pLp_His3014_TH_ DC-seq  pSIP plasmid that expresses a fusion protein consisting of a in-house 
constructed N-terminal His6-tag, 3014, TH, DC-seq. 
Designed for intracellular protein production and do not contain 
signal peptide. 
pLp_0373_TH_ DC-seq _2578 pSIP plasmid that expresses a fusion protein consisting of 0373 (N-
terminal SP from lp_0373), TH, DC-seq and 2578 (C-terminal 
LPxTG anchor from lp_2578). 
pLp_1261_TH_ DC-seq pSIP plasmid that expresses a fusion protein consisting of 1261 (N-
terminal lipobox from lp_1261), TH and DC-seq. 
pLp_3014_TH_ DC-seq pSIP plasmid that express a fusion protein consisting of 3014S, TH 
and DC-seq. 
For more details of the parts of the fusion proteins see section 1.3, section 1.5 and section 1.6 
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Table 2.4 Insert gene and constructs from other sources 
Insert genes and 
constructs from other 
sources 
Description Source 
   
2162S_AgESAT 2162S (has two N-terminal LysM-domains from 
lp_2162) fused with two M. tuberculosis antigens 
(Ag85 and ESAT-6) 
PEP group, 
NMBU 
3014S_AgESAT 3014S (truncated 3014 LysM with one N-terminal 
LysM-domain) fused with two M. tuberculosis 
antigens (Ag85 and ESAT-6) 
PEP group, 
NMBU 
pET16bChiA pET-16b plasmid that expresses chitinase A Anne Grethe 
Hamre, NMBU 
pEV pSIP plasmid with no insert gene PEP group, 
NMBU 
pLp_0373_OFA_cwa2 pSIP plasmid that expresses a fusion protein with 
0373-N-terminal SP, OFA (37-kDa oncofetal 
antigen from mammalian tumors) and cwa (2578-
LPxTG-anchor) 
(Fredriksen et 
al., 2010) 
pLp_1261_Inv pSIP plasmid that expresses a fusion protein 
consisting of 1261-lipobox-anchor fused with 
invasin 
(Fredriksen et 
al., 2012) 
pLp_3014_Inv pSIP plasmid that expresses a fusion protein 
consisting of 3014-LysM-anchor fused with 
invasin 
(Fredriksen et 
al., 2012) 
pUC_TH_DC-seq Commercial pUC plasmid that expresses a fusion 
protein consisting of with TH and DC-seq 
Merck  
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2.2 Primers.and.restriction.enzymes.
Table 2.5 Primer sequence (for description, see Table 2.6) 
Primers sequence Sequence  
  
Seq F GGCTTTTATAATATGAGATAATGCCGAC   
Seq RR AGTAATTGCTTTATCAACTGCTGC   
pET SeqF CCCCTCTAGAAATAATTTTGTTTAACTTT 
pET SeqR GCAGCCAACTCAGCTTC 
Mtb.HspX SeqF GGTGATATGGCTGGTTATGC 
pET 3014 F TCGAAGGTCGT CATATG GACTCAACTTACACCGTTAAGAGC  
pET Mtb.HspX F TCGAAGGTCGT CATATG TCTCAAATTATGTACAACTATCCTG 
pET Mtb.HspX R CAGCCGGATC CTCGAG TTAGTTAGTTGAACGAATTTGAATGTGC 
pET Mtb.HspX_DC R  CAGCCGGATC CTCGAG TTATGGTCTTTGTGGAGTAGAGT  
pET 2162 F TCGAAGGTCGT CATATG GCCTCAATCACTGTAAAAGCAAA  
pLp 0373_TbH_DC-seq F TGCTTCATCAGTCGACTCTCAAATTATGTACAACTATCCTG  
pLp TbH_DC-seq_2578 R GTTCAGTGACACGCGTTGGTCTTTGTGGAGTAGAGTGATAT  
pLp His3014uSP F 
 
GGAGTATGATCATATGCATCATCACCACCACCATGCTGCTGCTG 
CTGACTCAACTTACACCGTTAAGAG 
pLp TbH_DC R CCGGGGTACCGAATTCTTATGGTCTTTGTGGAGTAGAGTG  
pLp His_TH_DC F 
 
GAGTATGATTCATATGCATCATCACCACCACCATGCTGCTGCTG 
CTGTCGACATGTCTCAAATTATGTACA   
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Table 2.6 Primer descriptions. Primers were used for sequencing of plasmids and for recombining plasmids using the In-
Fusion® Cloning Kit 
Description of primers Description  Restriction 
site 
   
Seq F Forward primer for sequencing pSIP plasmids    
Seq RR Reverse primer for sequencing pSIP plasmids   
pET SeqF Forward primer for sequencing pET-16b plasmids  
pET SeqR Reverse primer for sequencing pET-16b plasmids   
Mtb.HspX SeqF 
 
Forward primer for sequencing pET-16b plasmids containing 
TH 
 
pET 3014 F 
Forward primer for pET-16b plasmids with 3014-LysM.  
Used for In-Fusion® Cloning 
NdeI 
pET MTtbHspX F 
 
Forward primer for pET-16b plasmids with TH.  
Used for In-Fusion® Cloning 
NdeI 
pET MTtbHspX R 
 
Reverse primer for pET-16b plasmids with TH. 
Used for In-Fusion® Cloning 
XhoI 
pET MtbHspX_DC R  
 
Reverse primer for pET-16b plasmids with TH_DC-seq. 
Used for In-Fusion® Cloning 
XhoI 
pET 2162 F 
 
Forward primer for pET-16b plasmids with 2162-LysM. 
Used for In-Fusion® Cloning 
NdeI 
pLp 0373_TbH_DC F 
 
Forward primer for pSIP plasmids with LPxTG anchor. 
Used for In-Fusion® Cloning 
SalI 
pLp TbH_DC_cwa2 R 
 
Reverse primer for pSIP plasmids with LPxTG anchor. 
Used for In-Fusion® Cloning 
MluI 
pLp His3014uSP F 
 
Forward primer for pSIP plasmids with His-tagged 3014-LysM. 
Used for In-Fusion® Cloning 
NdeI 
pLp TbH_DC R 
 
Reverse primer for pSIP plasmids with TH_DC-seq. 
Used for In-Fusion® Cloning 
EcoRI 
pLp His_TH_DC F 
 
Forward primer for pSIP plasmids with His-tagged TH_DC-
seq. 
Used for In-Fusion® Cloning 
NdeI, SalI 
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Table 2.7 Restriction enzymes and buffer 
Restriction enzymes and buffer Supplier 
  
FastDigest: 
FastDigest EcoRI 
FastDigest NdeI 
FastDigest SalI 
FastDigest XhoI 
FastDigest Green Buffer 
Thermo Scientific 
 
2.3 Antibodies.
Table 2.8 Antibodies 
 Supplier 
Primary antibodies:  
Monoclonal Mouse-anti-HspX, alpha crystalline  Acris Antibodies GmbH 
Penta-His™ Antibody, BSA-free (100μg), mouse Qiagen 
Polyclonal rabbit antibody to TB10.4  Antibodies-online GmbH 
  
Secondary antibodies:  
Goat Anti-Rabbit IgG-HRP SouthernBiotech 
Polyclonal Rabbit Anti-Mouse Immunoglobulins/HRP Dako 
Anti-Mouse IgG FITC-antibody Sigma-Aldrich 
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3 Methods..
3.1 Buffers.and.solutions.
Buffers..  
Buffer A (for protein purification) 100 mM Tris- pH8 
150 mM NaCl 
0.5 mM Imidazol 
 
Buffer B (for protein purification) 100 mM Tris- pH8 
150 mM NaCl 
300 mM Imidazol 
 
Lysis buffer 16 μl DNase I 
16 μl Lysozyme, 1 mg/ml 
16 ml Buffer A 
 
10X PBS 80 g NaCl 
2.0 g KCl 
18.05 g Na2HPO4!2H2O 
2.4 g KH2PO4 
Dissolve in dH2O and adjust pH to 7.4. 
Adjust volume to 1 l with dH2O. 
Sterilize by autoclaving at 121°C in 15 
minutes.  
 
10X TBS 1.5 M NaCl 
0.1 M Tris-HCl, pH 7.5 
Sterilize by autoclaving at 121°C in 15 
minutes.  
 
50X TAE 242 g Tris-Base 
57.1 ml Acetic acid 
100 ml 0.5M EDTA pH8 
Adjust volume to 1 l with dH2O 
 
  METHODS 
 
 19 
TEN buffer 5 ml Tris-HCL pH8 
1 ml 0.5M EDTA pH8 
50 ml 1M NaCl 
 
1M Tris 60.55 g Tris-Base 
Adjust pH to 8  
Adjust volume to 500 ml with dH2O. 
Sterilize by autoclaving at 121°C in 15 
minutes. 
 
  
  
Chemical.solutions.  
0.5 M EDTA  93.05 g EDTA!2H2O 
400 ml dH2O 
Adjust pH to 8 
Adjust volume to 500 ml with dH2O. 
Sterilize by autoclaving at 121°C in 15 
minutes.  
 
2M Glucose 36.032 g Glucose (anhydrate) 
Dissolve in dH2O and adjust volume to 10 
ml 
 
20 % Glycine (w/v) 20 g Glycine 
Dissolve in dH2O and adjust volume to 
100 ml 
Sterilize by autoclaving at 121°C in 15 
minutes.  
 
0.1 M IPTG (isopropyl β-D-1-
thiogalactopyranoside) 
0.2383 g IPTG 
Dissolve in dH2O and adjust volume to 10 
ml. 
 
Lysozyme, 1 mg/ml 100 mg Lysozyme 
Dissolve in dH2O and adjust volume to 1 
ml. 
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1 mM MgCl2 0.0508 g MgCl2!6H2O 
Dissolve in dH2O and adjust volume to 
250 ml. 
Sterilize by autoclaving at 121°C in 15 
minutes. Store at room temperature. 
 
30 % PEG 1500 40 g Polyethylen Glycol, PEG-1450 
Dissolve in dH2O and adjust volume to 
100 ml 
Sterilize by filtration with 0.45 µm syring 
filter and distribute in 1.5 ml microtubes. 
 
  
  
Antibiotic.stock.solutions.  
Ampicillin 50 mg/ml, 10mL 500 mg ampicillin sodium salt  
10 ml distilled water 
 
Sterilize by filtration with 0,22 µm syringe 
filter and distribute in 1,5 ml microtubes. 
Stored at -20°C. 
 
Erythromycin 100mg/ml, 10mL 1000 mg erythromycin  
10 ml 96% ethanol  
 
Sterilize by filtration with 0.22 µm syringe 
filter and distribute in 1.5 ml microtubes. 
Stored at -20°C. 
 
Erythromycin 10mg/ml, 10mL 100 mg erythromycin  
10mL 96% ethanol 
 
Sterilize by filtration with 0.22 µm syring 
filter and distribute in 1.5 ml microtubes. 
Stored at -20°C. 
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Medium.  
Brain-Heart-Infusion (BHI), liquid 
medium 
37 g dehydrated BHI broth per 1 litre of 
distilled water.  
Sterilize by autoclaving at 121°C in 15 
minutes. Store at room temperature 
 
Lysogeny broth / Luria 
Bertani broth (LB) 
10 g Bacto-Tryptone 
5 g Bacto-Yeast Extract 
10 g NaCl 
1 L dH2O 
 
Sterilize by autoclaving at 121°C in 15 
minutes. Store at room temperature 
 
Medium plates 1. 15 g agar-agar per 1 litre of liquid 
broth. Sterilize by autoclaving at 
121°C in 15 minutes.  
For selectivity: Add antibiotic to the 
solution when it is cooled down to 
approximately 50-60°C before the 
medium is poured in petri dishes.  
2. Store solidified medium plates at 4°C. 
Shelf-life depends on type of antibiotic 
added and recommendation provided 
by supplier. 
 
MRS (De Man, Rogosa, Sharpe) broth 52 g dehydrated MRS broth per 1 litre of 
distilled water.  
Sterilize by autoclaving at 121°C in 15 
minutes. Store at room temperature 
3.  
MRSSM Dissolve 17.1 g sucrose (0.5M) and 2 g 
MgCl2 (0.1M) in 100 ml MRS. Sterile 
filtrate with 0.45 μm syringe filter. 
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SOC medium 1. Dissolve in 60 ml dH2O: 
2 g Bacto™ Tryptone 
0.5 g Bacto™ Yeast Extract 
0.057 NaCl 
0.019 g KCl 
0.247 g MgSO4  
Stir with a magnetic stirrer 
2. Autoclave at 121°C in 15 minutes and 
let cool down to room temperature. 
3. Add 1 ml 2M glucose (Sterile filtrated) 
and adjust volume to 100 ml with 
dH2O. 
4. Store at -20°C in 1.5 ml and 10 ml 
aliquots. 
 
 
. .
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3.3 Cloning.
In-silico construction of plasmids was done using the software SerialCloner 2.6.1. 
Two different methods were used to recombine plasmid vector. One of the method was to 
digest plasmids using restriction enzymes and recombine by ligation using DNA ligase. 
The other method was to PCR-amplify an insert that consisted the insert gene and a 3’ and 
5’ extension that overlap with the plasmid vector, and recombining the linearized vector 
and insert with In-Fusion® Cloning Kit (more detail in section 3.2.5 and 3.2.8). 
3.3.1 Cultivation.of.bacteria.
 
Cultivation.of.Escherichia#coli.carrying.pET[16b.or.pUC.plasmid.
 
E.coli carrying pET-16b or pUC plasmid was grown either in 10 ml liquid broth 
(BHI or LB) medium or on medium plates (BHI or LB) containing 1.5% agarose. 200 
µg/ml or 100 µg/ml ampicillin was added to liquid media or media plates, respectively. 
E.coli grown in liquid medium were incubated overnight at 37°C in a shaking incubator, 
whereas E.coli grown on medium plates were incubated at 37°C in a incubator without 
shaking.  
   
Cultivation.of.Lactobacillus#spp..
Lactobacillus. spp without plasmid was grown in 10 ml liquid MRS medium. L. 
plantarum WCFS1 carrying pSIP plasmid was grown in 10 ml liquid MRS medium or on 
MRS plate with 200 µg/ml erythromycin. Lactobacillus. spp were all incubated overnight at 
30°C in a incubator without shaking. 
 
. .
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Long[term.storage.of.bacteria.
Liquid medium with bacteria were store at -80°C for long-term storage. Glycerol 
was added to prevent cell disruption due to ice crystallization. 
 
Material: 
Bacterial culture 
Glycerol solution, 85% (v/v) 
Procedure: 
1. Autoclave glycerol solution at 121°C for 15 minutes, chill and store at 4°C until use. 
2. Mix 1 ml bacterial culture and 300 µl glycerol solution in a cryogenic tube by pipetting 
or gentle vortexing. Store at -80°C. 
3.3.2 Isolation.of.plasmid.DNA.from.bacterial.cultures.
During plasmid DNA (pDNA) isolation, pDNA from E.coli was liberated by 
Sodium-Dodecyl-Sulfate/alkaline lysis. After the cell lysis step, a neutralization step was 
performed. pDNA will remain soluble after the neutralization step, and when adding the 
soluble fraction to the binding resin, negatively charged pDNA will bind to the positively 
charged resin. Contaminations of salts and EDTA and cell debris were washed away by 
ethanol precipitation and pDNA was eluted with a low ionic buffer solution.  
Different kits were used for pDNA isolation from E.coli due to the fact that these 
kits had different efficiency when used for different combination of host cell strains and 
plasmid constructs. The combinations were as listed: 
 
Plasmid DNA purification kit Construct and strains 
NucleoSpin® Plasmid Construct: pLp plasmids 
Strains: One Shot® BL21 Star™ (DE3) 
JetStar® 2.0 Plasmid Purification Kits Construct: pET and pUC plasmids 
Strain: Stellar™ Competent Cells 
 
 
.
.
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NucleoSpin®.Plasmid..
Material: 
NucleoSpin® Plasmid Kit 
Resuspension Buffer A1 
Lysis Buffer A2 
Neutralization Buffer A3 
Wash Buffer AW 
Wash Buffer A4 
Elution Buffer AE 
NucleoSpin® Plasmid Columns (white rings) 
Collection tubes 
1-5 ml E.coli over-night culture 
dH2O 
 
Procedure:  
1. Harvest cell pellet from 1-5 ml of E.coli culture by centrifugation at 11,000 x g for 30 
seconds. 
2. Resuspend the cell pellet with 250 µl of Buffer A1. 
3. Lyse resuspended cells by adding 250 µl Buffer A2 and invert the tube 6-8 times before 
incubating for 5 minutes at room temperature.  
NB! Do not vortex to reduce the risk of shearing genomic DNA. 
4. After incubation, add 300 µl of Buffer A3 to the suspension to neutralize and precipitate 
debris. Invert the suspension 6-8 times before centrifugation at 11,000 x g for 5-10 
minutes. Repeat if the supernatant is not clear enough. 
5. Meanwhile, prepare a NucleoSpin® Plasmid Column and collection tube for each 
sample. After centrifugation in step 4, pipette a maximum of 750 µl supernatant onto 
the column and centrifuge at 11,000 x g for 1 minute. Repeat if there is more 
supernatant left. Discard flow-through. 
6. Wash plasmid DNA that is now bound to the silica in the column, for salts with 600 µl 
Buffer A4 and centrifuge at 11,000 x g for 1 minute. Discard flow-through. 
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NB! For constructs with low plasmid DNA yields perform a washing step with 500 
µl Buffer AW before washing with Buffer A4. 
7. After washing step(s), dry the silica membrane by centrifugation at 11,000 x g for 2 
minutes and optionally air-dry for 2 minutes. 
8. After drying step, transfer the NucleoSpin® Plasmid Column to a 1.5 ml microtube for 
collection of plasmid DNA. Elute plasmid DNA by adding 25 µl of preheated Buffer 
AE or dH2O to the column and incubate for 3 minutes at 50°C before centrifugation at 
11,000 x g for 1 minute. Repeat the elution step, making a total elution volume of 50 µl. 
9. Measure DNA concentration (section 3.2.3) and proceed to further experiments or store 
at -20°C. 
(Adapted from the NucleoSpin® Plasmid manual from 2012) 
 
JetStar®.2.0.Plasmid.Purification.Kit,.Midiprep..
Material: 
JetStar® 2.0 Plasmid Purification Kit, Midiprep 
Cell Resuspending Buffer E1 
Lysis Buffer E2 
Precipitation Buffer E3 
Equilibration Buffer E4 
Wash Buffer E5 
Elution Buffer E6 
Isopropanol 
70% ethanol 
E.coli over-night culture 
 
Procedure adapted from supplier’s manual:  
1. Equilibrate JetStar™ Midi Column by adding 10 ml Equilibration Buffer (E4) onto the 
column and let it drain by gravity flow. This step takes about 10-15 minutes, so one 
could proceed with cell harvesting meanwhile.   
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2. Harvest cells by centrifugation at 12,000 x g for 2-3 minutes. Discard supernatant and 
add 4 ml of E1 to resuspend the cell pellet. Then transfer the cell suspension to a 15 ml 
nunc tube. 
3. Add 4 or 8 ml (for 25 or 50 ml culture respectively) of Lysis Buffer (E2) and invert 
gently until the suspension appeared homogenous. Incubated the homogenised 
suspension for maximum 5 minutes at room temperature. 
NB! Do not vortex to reduce the risk of shearing genomic DNA. 
4. Add 4 or 8 ml (for 25 or 50 ml culture respectively) of Precipitation Buffer (E3) to the 
suspension and immediately inverted until the suspension appeared homogenous.  
NB! Do not vortex to reduce the risk of shearing genomic DNA. 
5. Centrifuge the homogenous suspension from step 4 at 12,000 x g for 10 minutes at 
room temperature. Load supernatant onto the equilibrated column (from step 1) and let 
it drain by gravity flow.  
6. Wash column twice with 10 ml Wash Buffer (E5) and let it drain by gravity flow. 
Discard flow-through.  
7. After washing steps, place a new sterile nunc tube under column for elution. Load 5 ml 
of Elution Buffer (E6) onto the column and let it drain by gravity flow.  
8. Add 3.5 ml of isopropanol to the elution tube and mix well. Distribute the mixture to 6 
x 1.5 ml microtubes and centrifuge at 12,000 x g for 30 minutes at 4°C.  
9. Discard supernatant from step 8 by vacuum suction and wash with 3 ml 70% ethanol 
(approximately 500 µl per microtube) and centrifuge at 12,000 x g for 5 minutes at 4°C. 
10. Discard supernatant from step 9 by vacuum suction and let the DNA pellet air-dry at 
60°C.  
NB! Drying was checked approximately every 2 minutes to avoid overheating of the 
plastic that can cause DNA to be absorbed into it.  
11. Resuspend the DNA pellet in 30 µl dH2O. 
12. Measure DNA concentration (section 3.2.3) and proceed to further experiments or store 
at -20°C. 
(Adapted from the JetStar® 2.0 Plasmid Purification Kit manual from 2010) 
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3.3.3 Plasmid.DNA.concentration.measurement..
 The Qubit® dsDNA BR Assay Kit was used to measure plasmid DNA 
concentrations. This assays is a fluorescence-based quantification method using dye that is 
selective for double stranded DNA (“Qubit® dsDNA BR Assay Kits,” 2011). The assay 
was performed at room temperature (temperature fluctuations may influence accuracy). 
 
Material: 
Qubit® Fluorometer 
Qubit® dsDNA BR Assay Kit 
- Qubit® dsDNA BR reagent and buffer should be stored at room temperature 
- Qubit® dsDNA BR standard #1 and #2 should be stored 4°C 
Qubit® Assay tube 
Plasmid DNA 
 
Procedure (setup including standards): 
1. Make working solution by diluting Qubit® dsDNA BR reagent 1:200 in Qubit® 
dsDNA BR buffer in a 1.5 ml microtube.  
NB! Make a final volume of working solution so that there will approximately 
one sample volume in excess. 
2. For the assay, make a final volume of 200 µl for each sample or standard for calibration 
as followed: 
a. Standard: 10 µl of standard and 190 µl of working solution. 
b. Sample with plasmid: 1 or 3 µl of sample and 199 or 197 µl of working solution, 
respectively. 
Vortex the mixture for about 1-3 seconds and incubates for 2 minutes at room 
temperature. 
3. To measure concentration, choose the option “Use last calibration” and follow 
instructions on screen. 
a. To calibrate, choose the option “Run a new calibration” and follow instructions 
on screen. 
(Adapted from the Qubit® dsDNA BR Assay Kit manual from 2011) 
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3.3.4 Double.digestion.with.FastDigest®.restriction.enzymes.–.(Thermo.Scientific)..
Restriction enzymes type II was used to digest plasmid DNA. These types of 
restriction enzymes recognise their specific nucleotide sequence (usually 4-6 nucleotides 
long) and digest both DNA strands within the specific sequence. (Pray, 2008a). For an 
overview of the FastDigest® enzymes used in this study, see section 2.2.  
 
Materials: 
FastDigest® Enzymes 
FastDigest® Green Buffer 
Plasmid DNA 
Water bath 37°C 
 
Procedure: 
1. Make the reaction mix by combining the components in the following order: 
 Volume (μl) 
dH2O 15 
10X FastDigest Green Buffer 
(can be used as electrophoresis loading buffer) 
2  
(1X final concentration) 
Plasmid DNA 1 (up to 1 μg) 
FastDigest Enzyme 1 
FastDigest Enzyme  1 
Total volume (μl) 20 
NB! The combined volume of enzymes should not exceed 1/10 of the total volume. 
 
2. Mix gently and spin down. 
3. Incubate at 37°C in a water thermostat for the time as recommended by supplier (5-15 
minutes).  
4. Load the reaction mix directly on an agarose gel for gel electrophoresis (see section 
3.2.6). 
5. Excise the target gel band for clean-up (see section 3.2.7). 
(Adapted from Product information - Thermo Scientific FastDigest EcoRI. Rev 9 2012) 
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3.3.5 Polymerase.chain.reaction..
The polymerase chain reaction (PCR) is a technique applied for amplifying a 
specific DNA fragment (Pray, 2008b). The basic components for PCR are: DNA 
polymerase, template DNA, the four deoxyribonucleotides (substrate for DNA polymerase 
and raw material for new DNA strands), forward and reverse primers with exposed 3´OH 
groups and buffer. Primers are DNA sequences that are complementary to the outer end of 
the target DNA sequence. They have a free 3´OH group at their ends because DNA 
polymerase can only add new deoxyribonucleotides to a pre-existing 3´OH group. The 
forward and reverse primers are complementary to the sense and anti-sense DNA strands 
respectively. PCR are performed in test tube (PCR-tube) placed in a thermocycler (PCR 
machine). In general, each cycle of PCR contains of three main, temperature-dependent 
steps (figure 3.1): 
1. Denaturing of double DNA strands in high temperature between 90°C and 100°C. 
The high temperature breaks hydrogen bonds between the DNA strands. 
2. Hybridization steps by cooling to between 30°C and 65°C to let primers anneal to 
their complementary sequence of the now, single stranded DNA. The higher the 
temperature, the higher stringency of hybridization between primer DNA template.  
3. Elongation steps by heating to between 60°C and 75°C to let DNA polymerase 
synthesize new DNA strands from the 3´OH-ends of the primers and using the 
single stranded DNA as template.  
In principal, the amount of target DNA sequence doubles after each cycle of PCR.  
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Figure 3.1 Polymerase chain reaction (PCR) (This figure is from Scitable by Nature Education. © 2014 Nature 
Education. All rights reserved.)  
See section 2.2 for overview of the primers used in this study. 
 
Q5®.High[Fidelity.2X.Master.Mix.(New.England.Biolabs).
The Q5® High-Fidelity 2X Master Mix was used for PCR-amplification of 
fragments used for cloning with the In-Fusion® HD Cloning Kit (see section 3.2.8). 
Primers used for the In-Fusion® HD Cloning Kit are designed to produce inserts with a 
15bp extension, including the restriction sites, that overlap with the 5’ overhang of the 
linearized plasmid vector. Vectors used in this study contain restriction sites that give sticky 
ends, thus bases complementary to 5’ overhangs are included in the primer sequence and 
bases in the 3’ overhangs are not. 
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Materials: 
Q5 High-Fidelity 2X Master Mix (Q5 MaMix) 
10 μM Forward primer  
10 μM Reverse primer 
Plasmid DNA (template DNA source) 
dH2O 
6X Loading Dye 
PCR tubes 
PCR machine (thermocycler) 
 
Procedure: 
1. Use NEB Tm Calculator (http://tmcalculator.neb.com/#!/) to calculate the annealing 
temperature for the each specific primer pair.  
2. Make the reaction mix in a PCR tube on ice: 
 25 μl mix 50 μl mix  
Q5 MaMix 12.5 
(1X finale concentration) 
25 
(1X finale concentration) 
10 μM Forward primer 1.25 2.5 
10 μM Reverse primer 1.25 2.5 
Plasmid DNA variable variable  
(1 pg- 1 ng) 
dH2O to 25 μl to 50 μl 
 
3. Mix gently and collect all liquid at the bottom of the PCR tube by spinning shortly. 
4. Transfer the PCR tubes with reaction mix to a PCR machine and perform 
thermocycling using the following settings:  
  METHODS 
 
 33 
 
Step Temperature Time 
Initial denaturation 98°C 30 seconds 
25 cycles 
(may increase up to 35 cycles) 
98°C 10 seconds 
50-72°C 
(Annealing temperature as 
recommended by NEB Tm 
Calculator) 
20 seconds 
72°C 30 seconds 
Final extension 72°C 2 minutes 
Hold 10°C  
 
5. Store the PCR reaction mix in the refrigerator (for experiments the next day) or at -
20°C if gel electrophoresis is not going to be performed right after thermocycling. 
6. For gel electrophoresis: Add 5 μl or 10 μl of 6X Loading Dye to 25 μl or 50 μl PCR 
reaction mix, respectively (1X final concentration of loading dye).  
7. Load the sample(s) onto an agarose gel for gel electrophoresis (see section 3.2.6) to 
check for PCR product, and if applicable, excise and isolate the PCR product. 
(Adapted from the Q5® High-Fidelity 2X Master Mix manual from 2014) 
 
VWR.Red.Taq.DNA.Polymerase.Master.Mix.(VWR).
2x#Master#Mix#Kit#(1.5#mM#MgCl2)#
VWR Red Taq DNA Polymerase Master Mix was used to perform colony-PCR as a 
preliminary control of transformants (see section 3.2.9). PCR-products were loaded onto an 
agarose gel for gel electrophoresis. If target bands were observed, it strongly indicated 
successful transformations. An inert red dye is presented in the master mix to allow for 
direct loading of sample onto agarose gel for electrophoresis analysis (VWR International, 
2013). 
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Materials: 
Taq 2x Master Mix (Taq 2xMaMix) 
10 μM Forward primer  
10 μM Reverse primer 
Transformant colony (template DNA source) 
dH2O 
PCR tubes 
PCR machine (thermocycler) 
 
Procedure: 
1. Use NEB Tm Calculator (http://tmcalculator.neb.com/#!/) to calculate the annealing 
temperature for the each specific primer pair.  
2. Make the reaction mix in a PCR tube on ice: 
 50 μl mix  
Taq 2xMaMix  
(spin briefly before use) 
25  
(1X final concentration) 
10 μM Forward primer 1 
10 μM Reverse primer 1 
Transformant colony Pick a sample with a sterile toothpick and smear in 
the bottom of the PCR tube 
dH2O 23 
 
3. Mix gently and collect all liquid to the bottom of the PCR tube by spinning shortly. 
4. Transfer PCR tubes with reaction mix to a PCR machine and perform thermocycling 
using the following settings:  
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Step Temperature Time 
Initial denaturation 95°C 2 minutes 
30-35 cycles 
 
95°C 20 seconds 
50-65°C 
(annealing temperature as 
recommended by NEB Tm 
Calculator) 
25 seconds 
72°C 30 seconds 
Final extension 72°C 5 minutes 
Hold 10°C  
 
5. Store PCR reaction mix in the refrigerator (for experiments the next day) or at -20°C if 
gel electrophoresis is not going to be performed right after thermocycling. 
6. For gel electrophoresis: Load 10 - 30 % (5 – 15 μl) of the reaction mix volume directly 
onto an agarose gel and run gel electrophoresis analysis (see section 3.2.6) and check 
for PCR products with the expected size band. 
(Adapted from the VWR Red Taq DNA Polymerase Master Mix manual from 2013) 
 
3.3.6 DNA.separation.and.analysis.by.agarose.gel.electrophoresis..
Agarose gel electrophoresis was used to analyse and purify digested plasmid DNA 
and PCR products. The nucleic acid molecules are loaded into wells in cast agarose gel 
placed in a container filled with buffer. When an electric current is applied in the field, 
negatively charged nucleic acids migrate toward the anode (positive) pole (Yilmaz, Ozic, & 
Gök, 2012). As nucleic acids migrate through network of pores in the gel, they are 
separated by size differences, where smaller molecules migrate faster. The migration is 
visualized under UV light using a fluorescent DNA binding dye and appears as size 
dependent bands along the migration path. The desired “band”, meaning the desired DNA 
fragment, can be excised and the DNA fragment can purified (see section 3.2.7) for further 
experiments like transformation. A DNA fragment size standard is used to estimate the size 
of the DNA fragments. 
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Materials (agarose gel stock solution): 
Agarose (SeaKem® LE Agarose from Lonza, molecular biology grade) 
1X TAE buffer  
 
Procedure (agarose gel stock solution): 
1. Add 500 ml 1X TAE buffer to 6 g agarose (1.2 % v/w) and stir with a magnetic stirrer. 
Remove the magnet before autoclaving. 
2. Autoclave the agarose solution for 15 minutes at 121°C. 
3. Store in 50°C incubator. 
 
Materials (gel electrophoresis): 
1.2 % Agarose solution 
peqGREEN DNA and RNA dye (PEQLAB, VWR) 
Nucleic sample (section 3.2.4 and 3.2.5) 
6X DNA Loading Dye (Thermo Scientific) 
GeneRuler™ 1kb DNA Ladder (Thermo Scientific) 
Quick-Load® 1kb DNA Ladder (New England Biolabs) 
Gel caster 
Gel tray 
Comb, 8 wells 
Gel tank (Mini-Sub cell GT cell) 
PowerPac™ Basic Power Supply 
Gel Doc™ EZ system  
UV Sample Tray 
(Gel casting set-up and imaging device are from Bio-Rad) 
 
Procedure (gel electrophoresis): 
1. Prepare for gel casting by placing the gel tray on the gel caster. Place the comb at one 
end of the gel tray. Make sure that the gel caster is flat so that agarose solution can 
distribute evenly for even thickness of the gel. 
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2. Add 2.5 μl peqGREEN to 60 ml of agarose solution. Swirl gently to mix solution before 
pouring into the gel tray. Use a pipette tip to remove bubbles if there are any. Allow the 
gel to polymerize for at least 15-20 minutes at room temperature. After polymerization, 
transfer gel to a gel tank and fill tank with 1X TAE buffer until the mark indicating 
maximum volume.  
3. Add5 μl 6X DNA Loading Dye to 25 μl sample (1X final concentration). 
a. PCR-products that contain VWR Red Taq DNA Polymerase Master Mix are 
already loaded and dyed. 
4. Pipette samples and molecular marker into the wells: 
- 10 μl GeneRuler™ or Quick-Load® and  
- 30 μl loaded Q5® PCR-product (section 3.2.5, first part) 
- 15 μl VWR Red Taq PCR-product (section 3.2.5, second part) 
- Whole volume of digested pDNA (section 3.2.4) 
5. Close the lid of the gel tank and connect to the PowerPac™ Basic Power Supply. Run 
electrophoresis at 70 volt for 45 – 60 minutes. 
6. Visualize nucleic acids with Gel Doc™ EZ system on an UV sample tray.  
7. Excise desired DNA fragments for further analysis if necessary.  
 
3.3.7 DNA.fragment.purification.from.agarose.gel..
To purify DNA fragments from an excised agarose gel, the gel was mixed with 
binding buffer and dissolved by heating. Chaotropic salt in binding buffer make it possible 
for DNA to bind to the silica in the purification column, and a pH indicator in the buffer 
ensure pH for optimal binding (colour of the dissolved agarose gel should be yellowish) of 
DNA (“NucleoSpin® Gel and PCR Clean-up Kit,” 2013). 
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Material: 
NucleoSpin® Gel and PCR Clean-up Kit 
Buffer NTI 
Buffer NT3  
Buffer NE 
NucleoSpin® Gel and PCR Clean-up Columns (yellow rings) 
Collection tubes 
dH2O 
Water bath, 50°C 
 
Procedure: 
1. For each 100 mg of agarose gel, add 200 μl of Buffer NTI (binding buffer) and incubate 
sample for 5-10 minutes at 50°C water bath. Vortex briefly for every 2-3 minutes until 
the gel is completely dissolved.  
2. Prepare a NucleoSpin® Gel and PCR Clean-up Column and collection tube for each 
sample. Load a maximum of 750 µl sample onto the column and centrifuge at 11,000 x 
g for 1 minute. Repeat if there is more sample left. Discard flow-through. 
3. Wash plasmid DNA, bound to the silica in the column, with 700 µl Buffer NT3 and 
centrifuge at 11,000 x g for 1 minute. Discard flow-through.  
4. After washing step, dry the silica membrane with centrifugation at 11,000 x g for 2 
minutes and optionally air-dry for 2 minutes. 
5. After drying step, transfer the NucleoSpin® Gel and PCR Clean-up Column to a 1.5 ml 
microtube for collection of DNA. Elute plasmid DNA by adding 15 µl of preheated 
Buffer NE or dH20 to the column and incubate for 3 minutes at 50°C before 
centrifugation at 11,000 x g for 1 minute. Reload the NucleoSpin® Gel and PCR Clean-
up Column with the eluted volume of plasmid DNA (15 μl) and repeat the elution step. 
6. Measure DNA concentration (section 3.2.3) and proceed to further experiments or store 
at -20°C. 
(Adapted from the NucleoSpin® Gel and PCR Clean-up Kit manual from 2013) 
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3.3.8 Recombining.linearized.plasmid.and.DNA.insert.
As mentioned, two different methods were used to recombine plasmid vector. One 
of the method was to digest plasmids using FastDigest® restriction enzymes and recombine 
by ligation using DNA ligase. The other method was to PCR-amplify an insert that 
consisted the insert gene and a 5’-end and a 3’-end extension that overlap with the plasmid 
vector, and recombining the linearized vector and insert with In-Fusion® Cloning Kit. 
 
In[Fusion®.HD.Cloning.Kit.
In-Fusion® HD Cloning Kit was used for recombining linearized vector plasmid 
(section 3.2.4) and PCR amplified insert (section 3.2.5).  
 
Materials: 
Vector (linearized plasmid) 
Insert (purified PCR product) 
5X In-Fusion HD Enzyme Premix 
dH2O 
Water bath, 50°C 
 
Procedure: 
1. Make the reaction mix in a 1.5 ml microtube: 
 10 μl mix 
5X In-Fusion HD Enzyme Premix 2 
Linearized vector plasmid * 50-200 ng 
Purified PCR insert * 10-200 ng 
dH2O To 10 μl 
In general, good efficiency is achieved with 50-200 ng of vector and inserts, 
respectively.  
* If the volume of vector and inserts excess 7 μl, double the amount of 5X In-Fusion 
HD Enzyme Premix and add dH2O to a total volume of 20 μl. 
2. Incubate reaction mix for 15 minutes at 50°C in a water bath. 
3. Chill on ice after incubation and proceed to transformation or store at -20°C until 
needed for transformation. 
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(Adapted from the In-Fusion® HD Cloning Kit manual from 2011) 
 
Quick.Ligation™.Kit..
Quick Ligation™ Kit was used to recombine digested plasmid of vector and insert. 
 
Materials: 
Linearized vector plasmid  
Linearized insert plasmid 
2X Quick Ligation Buffer 
Quick Ligase 
dH2O 
 
Procedure: 
1. In general, mix 50 ng of vector and 3-fold molar excess of insert. Use NEBioCalculator 
(http://nebiocalculator.neb.com/#!/) to calculate the vector-insert ratio.  
2. Adjust volume to 10 μl with dH2O. 
3. Add 10 μl 2X Quick Ligation Buffer and mix. 
4. Add 1 μl Quick Ligase and mix thoroughly.  
5. Spin briefly and incubate for 5 minutes at room temperature. 
6. Chill on ice after incubation, then transform or store at -20°C until needed for 
transformation. 
Do not heat inactivate, because this will dramatically reduce transformation efficiency. 
(Adapted from the Quick Ligation™ Kit manual, accessed from New England Biolabs 
website in 2014) 
 
3.3.9 Transformation.of.E.#coli..
Recombinant plasmid DNA was introduced into competent E. coli host cell by 
transformation, see section 2.1 for an overview of the combinations of strains and plasmid, 
and for an overview of the antibiotic used. Chemically competent cells were used for 
transformation. These cells are transformable because they have been treated with buffer 
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that contain CaCl2 and other salts that partially disrupt the cell membrane, making it 
possible for plasmids to pass into the cell (“Competent Cell Compendium: Tools and Tips 
for Successful Transformations,” 2006). After transformation, the cells are diluted in rich 
media to recover before cultivation on selective media.  
 
Materials: 
Ligation mix 
Competent E.coli 
S.O.C. medium 
Medium plates with antibiotics 
Water bath, 42°C 
 
Procedure (New England Biolabs): 
1. Thaw competent cells on ice for at least 5-10 minutes. 
2. Add 5 ng (or 2 μl) of ligation mix to 50 μl of competent cells in a 1.5 ml microtubes or 
a falcon tube. Mix by pipetting up and down or flicking the tube 4-5 times. Do not 
vortex. 
3. Place the mixture on ice for 30 minutes without mixing. 
4. Heat shock at 42°C for 30 seconds. 
NB! Duration and temperature may be adjusted according to recommendation 
provided by the manufacture of the competent cells. 
5. Add 950 μl S.O.C. medium and incubate for 60 minutes at 37°C in a shaking incubator. 
NB! The type of medium and amount may be adjusted according to 
recommendation provided by the manufacture of the competent cells. 
6. Pre-warm selection plates to 37°C. 
7. Spread 50 and 100 μl of the transformation mix onto plates and incubate overnight at 
37°C. 
(Adapted from New England Biolabs’ manual for transformation, accessed from New 
England Biolabs website in 2014) 
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3.3.10 Confirmation.of.successful.transformation.into.host.cell.
To confirm successful transformation, transformants were checked preliminary by 
colony-PCR (section 3.2.5) and sent to GATC Biotech for LIGHTrun™ Sequencing for a 
final confirmation. Each transformant colony tested was subjected to colony-PCR and 
overnight cultivation (section 3.2.1 for cultivation).  Plasmid DNA isolated from overnight 
culture was sent to GATC Biotech LIGHTrun™ Sequencing for DNA sequencing and 
results were analysed using CLC Genomics Workbench 5. 
 
Materials for LIGHTrun™ Sequencing: 
Plasmid DNA isolated from overnight culture (section 3.2.2) 
Sequencing forward and reverse primers, 10 μM (section 2.2) 
dH2O 
Barcode from GATC Biotech (for identification of samples) 
 
Procedure for LIGHTrun™ Sequencing: 
1. Mark one 1.5 ml microtube with barcode. One barcode for each primer. 
2. Make the reaction mix in the barcode-marked 1.5 ml microtube: 
Plasmid DNA 400 -  500 ng 
Primer 2.5 μl 
dH2O to 11 μl 
 
3. Read results using CLC Genomics Workbench. 
3.3.11 Electroporation.with.electrocompetent.L.#plantarum#WFCS1.
To express fusion proteins used in this study in L. plantarum WCFS1 purified 
plasmid DNA was transformed to the microbe by electroporation. In an electroporation 
device mixture of cells and plasmids is subjected to a pulse of electricity. The pulse of 
electricity temporarily disrupts the cell membranes and for a short moment, allow plasmids 
to pass through (“Competent Cell Compendium: Tools and Tips for Successful 
Transformations,” 2006). L. plantarum WCFS1 was made electrocompetent prior to 
electroporation according to (Aukrust, Brurberg, & Nes, 1995) 
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Preparing.Electrocompetent.L.#plantarum#WCFS1.
Materials: 
2X MRS (section 3.2.1, double amount of MRS) 
MRS 
20 % glycine (w/v) 
30 % PEG-1500 
MgCl2 
TEN buffer 
L. plantarum WCFS1 overnight culture 
Chilled Corex tube  
Ice 
 
Procedure: 
1. Dilute L. plantarum WCFS1 overnight culture with MRS to absorbance at OD600 
(optical density at 600 nm) = 0.5-0.7.  
2. Add 5-10 ml of the diluted culture to a 50 ml Nunc tube containing 20 ml 2X MRS, 5 
ml 20% glycine and 5-10 ml dH2O (total volume should be 40 ml). 
• Make a negative sample by replacing the culture with MRS.  
3.  Measure the absorbance at OD600 and incubate at 30°C until about 2.5 generation has 
passed (absorbance of about 1.0). 
• Glycine inhibits formation of crosslinkage in the cell wall and enhances 
transformability.  
4. After incubation, chill the sample on ice and harvest by centrifugation at 5000 x g for 5 
minutes at 4°C. It is important to keep cells cool to maximise transformation efficiency. 
Discard supernatant. 
• Chill a Corex tube and 10 1.5 ml microtubes on ice for later. 
5. Wash cell pellet with 10 ml chilled TEN buffer. Centrifuge at 5000 x g for 5 minutes at 
4°C. Discard supernatant. 
6. Wash with 40 ml chilled 1mM MgCl2 and centrifuge at 5000 x g for 5 minutes at 4°C. 
Discard supernatant. 
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7. Resuspend cell pellet in 5 ml 30% PEG-1500 and transfer to a chilled Corex tube. 
Centrifuge at 5000 x g for 10 minutes at 4°C. Discard supernatant.  
8. Resuspend cell pellet in 400 μl 30% PEG-1500 and distribute into 40 μl aliquots in 
chilled 1.5 ml microtubes. Store at -80°C. 
 
Electroporation.of.L.#plantarum.WCFS1..
Materials: 
Electrocompetent L. plantarum WCFS1 
MRSSM medium 
MRS plate with erythromycin 
Electroporation cuvette 
Electroporator 
Ice 
 
Procedure: 
1. Chill MRSSM and cuvette on ice. 
2. Mix 40 μl electrocompetent L. plantarum WCFS1 and 5 μl plasmid DNA and 
immediately transfer to the chilled cuvette. Tap gently to mix and avoid air bubbles. 
3. Adjust the Electroporator to the following parameter: 
- Tension 1.5 kV 
- Capacitance 25 mF 
- Resistance 400 W 
4. Place cuvette in the electroporation device and deliver the tension pulse. 
5. Add 950 μl chilled MRSSM to the cuvette and mix by pipetting up and down. 
6. Transfer the mixture to a 1.5 ml microtube and incubate at 30°C for at least 2 hours and 
overnight at most. 
7. Streak 50 and 100 μl of the cell suspension on MRS plate with erythromycin and 
incubate at 30°C overnight. 
(Adapted from Aukrust et al., 1995) 
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3.4 Protein.production..
3.4.1 Intracellular.protein.production.and.extraction.of.protein.in.E.#coli.
pET-16b constructs made in this study were all made for intracellular expression. 
To purify fusion proteins, overproducing E. coli cells were lysed by sonication and the 
soluble fraction was used for protein purification with immobilized metal ion affinity 
chromatography (IMAC). The pET-16b vector include a coding sequence for a N-terminal 
His-tag that enable production of His-tagged fusion proteins that can be purified by IMAC 
by employing the interaction between histidine residues and the immobilized metal ion 
(more detail in section 3.3.4).  
In the pET-16b expression vector the gene of interest is under the control of 
bacteriophage T7 transcription signal and expression is induced in host cells that provide 
T7 RNA polymerase (Novagen, 2011). pET-16b vectors were transferred to E. coli that 
contains the T7 RNA polymerase gene under the lacUV5 promoter. Expression of the T7 
RNA polymerase was induced by addition of isopropyl β-D-1-thiogalactopyranoside 
(IPTG), a molecular mimic of allolactose.  In general a final concentration of 0.4 mM IPTG 
was used. In this study an induction experiment was performed testing three different 
concentrations of IPTG (0.04 mM, 0.1 mM and 0.4 mM) and induction at 10°C and 18°C. 
See results for more details. 
 
Materials: 
Day 1: 3 ml overnight LB culture of E. coli carrying plasmid 
400 ml LB broth with ampicillin (200 µg/ml) 
Day 2: 0.4 mM IPTG  
Day 3:  Lysis buffer 
0.22 μm syringe filter 
50 mM PMSF 
 
Procedure: 
1. Day 1: Transfer 3 ml overnight LB culture of E. coli to 400 ml LB broth with ampicillin 
and incubate overnight at 18°C in shaking incubator. 
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2. Day 2: Induce expression with IPTG at a final concentration of 0.4 mM when 
absorbance at OD600 is between 0.5 – 1.5. Incubate overnight at 18°C in shaking 
incubator. 
Day 3:  
3. Harvest the cells by centrifugation at 5000 x g for 10 minutes at 4°C. Discard 
supernatant. 
4. Resuspend the cell pellet in 16 ml lysis buffer and incubate at room temperature for 20 
minutes with occasional shaking. For convenience, transfer cell suspension to a 50 ml 
Nunc tube. 
5. Place the tube with cell suspension in ice to cool down suspension during sonication. 
Submerge the sonication probe approximately 1 cm into the cell suspension and make 
sure it does not touch the wall of the tube. Sonicate with these parameters: 
- 20 % amplitude 
- 5 seconds ON/OFF 
- 5 minutes (total of ON time) 
6. Spin down cell debris at 10,000 x g for 10 minutes at 4°C. Transfer supernatant to a 
clean container. Sterile filtrate the supernatant with 0.22 μm syringe filters and add 
PMSF (2 μl per 1 ml).  
7. Store in refrigerator or proceed directly to further experiment and analysis. 
3.4.2 Intracellular.protein.production.and.extraction.of.fusion.protein.in.L.#plantarum#
WCFS1.
Intracellular protein production in L. plantarum WCFS1 was done using a 
derivative of the pSIP400-series (termed pLp hereafter) that contains the promoter for 
sakacin P (Sørvig et al., 2003). Expression was induced by addition of the peptide 
pheromone SppIP. SppIP leads to phosphorylation of a membrane located histidine kinase, 
which then activates a response regulator that binds to, in this case, the regulated sakacin P 
promoter and thus induce expression of the target gene that is under the control of the 
sakacin P promoter. 
To purify fusion proteins from L. plantarum WCFS1, cells were lysed by sonication 
and the soluble fraction was used for protein purification with IMAC. pLp vectors do not 
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contain coding sequence for N-terminal His-tag, thus a construction of insert gene that 
contain coding sequence for a N-terminal His6-tag was constructed in this study to produce 
fusion protein with His-tag that could be purified by IMAC (more detail in section 3.3.4).  
 
Materials: 
Overnight culture L. plantarum WCFS1 carrying plasmid 
500 ml MRS broth with erythromycin (200 µg/ml) 
Inducer peptide SppIP, 100 μg/ml stock solution 
Lysis buffer 
0.22 μm syringe filter 
50 mM PMSF 
 
Procedure: 
1. Dilute the overnight culture to an absorbance at OD600 = 0.1 500 ml MRS with 
erythromycin. 
2. Incubate the diluted culture at 30°C in an incubator without shaking. Add 25 ng/ml 
SppIP when OD600 = 0.3. Incubate the culture for 5 hours. 
3. Harvest the cells by centrifugation at 5000 x g for 10 minutes at 4°C. Discard 
supernatant. 
4. Resuspend the cell pellet in 16 ml lysis buffer and incubate at room temperature for 20 
minutes with occasional shaking. For convenience, transfer cell suspension to a 50 ml 
Nunc tube. 
5. Place the tube with cell suspension in ice to cool down suspension during sonication. 
Submerge the sonication probe approximately 1 cm into the cell suspension and make 
sure it does not touch the wall of the tube. Sonicate with these parameters: 
- 30 % amplitude 
- 5 seconds ON/OFF 
- 15 minutes (total of ON time) 
6. Spin down cell debris at 10,000 x g for 10 minutes at 4°C. Transfer supernatant to a 
clean container. Sterile filtrate the supernatant with 0.22 μm syringe filters and add 
PMSF (2 μl per 1 ml).  
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7. Store in refrigerator or proceed directly to further experiment and analysis. 
 
3.4.3 Displaying.fusion.proteins.on.cell.surface.of.L.#plantarum#WCFS1.
Production of fusions proteins with surface anchors for direct display on cell surface 
of L. plantarum WCFS1 was done using the pLp expression vector (see above for more 
detail about the pSIP system).  
For analysis of protein production, induced L. plantarum WCFS1 carrying plasmid 
was analysed with flow cytometry or Western blot. For Western blot analysis, cells were 
lysed with FastPrep®-24 homogenizer and the cell-free extract was analysed.  
 
Materials: 
Overnight culture L. plantarum WCFS1 with recombinant plasmid 
50 ml MRS broth with erythromycin (200 µg/ml) 
Inducer peptide SppIP, 100 μg/ml stock solution 
1X PBS 
Glass beads, acid washed <106 μm 
FastPrep®-24 homogenizer and tubes  
 
Procedure: 
1. Dilute the overnight culture to an absorbance at OD600 = 0.1 in a Nunc tube with 50 ml 
MRS with erythromycin. 
2. Incubate the diluted culture at 30°C in an incubator without shaking. Add 25 ng/ml 
SppIP when OD600 = 0.3. Incubate the culture for 2-5 hours. 
3. Harvest cells by centrifugation at 3000 x g for 5 minutes at 4°C. Discard supernatant.  
4. Wash cell pellet 2 times with 10 ml 1X PBS and use the same centrifugation parameters 
as in step 3. 
Cell disruption with acid washed glass beads for Western blot analysis: 
5. Store cell pellet at -20°C or resuspend cells in 1 ml 1X PBS. 
6. Weigh in 0.5 – 0.6 g glass beads in a FastPrep®-24 tube and transfer the cell suspension 
from step 5 over to the tube. 
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7. Disrupt cells with the FastPrep®-24 homogenizer using the following parameters: 6.5 
m/s and 45 seconds 
8. Centrifuge disrupted cells at 16,000 x g for 5 minutes at 4°. Transfer supernatant to a 
1.5 ml microtube. 
9. Repeat the centrifugation at step 8 to remove residues of glass beads. Transfer the 
supernatant to a new 1.5 ml microtube. 
10. Store the cell-free extract at -20°C or proceed to further experiment and analysis. 
 
3.4.4 Protein.purification.by.immobilized.metal.ion.affinity.chromatography.(IMAC).
Immobilized metal ion affinity chromatography (IMAC) was performed to purify 
polyhistidine tagged fusion protein from the soluble fraction of cell-free protein extract. 
This procedure is based on interaction between the immobilized Ni2+ ions and the 
polyhistidine tag in the fusion proteins. Protino® Ni-NTA Agarose beads consists of 
nitrilotriacetic acid (NTA), a tetradentate chelator, that is immobilized on 6 % agarose 
beads (“Purification of His-tag proteins - User manual Protino® Ni-NTA Agarose, 
Protino® Ni-NTA Columns 1 mL, Protino® Ni-NTA Columns 5 mL,” 2013). The chelator 
occupies four of six of the binding sites of Ni2+. The two binding sites left are usually 
occupied with water molecules that are exchangeable with histidine residues in fusion 
protein (figure 3.2).  A buffer with a competing agent, imidazole in this case, can then elute 
fusion protein with histidine tag.  
 
 
 
Figure 3.2 NTA in complex with Ni2+ (This figure was taken from “Purification of His-tag proteins - User manual 
Protino® Ni-NTA Agarose, Protino® Ni-NTA Columns 1 mL, Protino® Ni-NTA Columns 5 mL” 2013) 
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Materials: 
Soluble fraction of cell-free protein extract (keep on ice throughout purification) 
Buffer A 
Buffer B 
20 % Ethanol 
Protino® Ni-NTA Agarose  
BioLogic™ LP System 
Ni-NTA Column 
 
Procedure: 
1. Pack a column with approximately 5 ml Protino® Ni-NTA Agarose and allow the 
beads to sink for 15-30 minutes. Avoid air bubbles. 
2. Run Buffer A through the system with 1.5 mg/ml flow rate for about 10 minutes. This is 
the baseline (background signal). Zero the baseline by pressing the “UV” button on the 
instrument and choose “Zero”. 
3. Stop the flow and move the aspiration tube to the sample tube. Run the sample through 
the system. The curve in the chromatogram will begin to climb upward which indicates 
detection of the flow-through of waste products. Collect the flow-through for later 
analysis. 
4. When the entire sample has passed the system, run Buffer A through the system again. 
The curve in the chromatogram will start to climb downward and let Buffer A flow 
through the system till the chromatogram has been showing a flat line for 5 minutes. 
5. Move the aspiration tube to Buffer B to elute fusion protein and start collecting the 
eluate in a clean tube. Base line will usually be higher because of higher imidazole 
concentration, and the eluate-peak will usually be smaller than the flow-through. 
6. After collecting the eluate, move aspiration tube back to 20 % ethanol and direct the 
flow back to the waste tank. Rinse by purging the system with 20 % ethanol. 
7. Protino® Ni-NTA Agarose, now in  20 % ethanol, can be transferred to a 15 ml Nunc 
tube and store at 4°C to be reused later.  
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3.5 Evaluative.analysis.of.protein.production.
Protein production was analysed and checked with protein gel electrophoresis, 
Western blot or flow cytometry. To measure protein concentration, the Bradford method 
was used. 
3.5.1 Measuring.protein.concentration.with.the.Bradford.protein.assay.
The method of Bradford was used to measure protein concentration in solution. This 
method is a dye-binding assay in which Coomassie blue, an acidic dye, undergoes a colour 
change upon binding to protein (“Bio-Rad Protein Assay - LIT33 Rev C,” n.d.). The colour 
change is then measured at 595 nm and concentration can be calculated using a standard 
curve. The dye binds primarily to basic and aromatic amino acid residues, especially 
arginine.  
 
Materials: 
1X Dye Reagent Concentrate (room temperate) 
Buffer A 
Protein sample (set up parallels)  
BioPhotometer and cuvettes 
 
Procedure: 
1. Cool 1X Dye Reagent Concentrate to room temperature. 
2. Blank sample: 800 μl Buffer A  
3. Protein sample: 10 μl sample + 790 μl Buffer A 
4. With about 30 seconds in between each sample, add 200 μl 1X Dye Reagent 
Concentrate to the blank sample and the protein samples. Pipette or vortex to mix 
samples thoroughly.  
5. Incubate at room temperature for at least 5 minutes and maximum for 60 minutes. 
6. Use the “Bradford micro” program and reset BioPhotometer with the blank sample. All 
samples, including blank, has to be incubated with dye reagent for the same amount of 
time. Thus it is important to measure following samples at the exact time difference 
between the additions of dye reagent to samples.  
(Adapted from the Bio-Rad Protein Assay – LIT33 Rev C manual) 
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3.5.2 Sodium.dodecyl.sulphate.–.polyacrylamide.gel.electrophoresis.
To examine the efficiency of protein production, protein content of harvested 
samples were separated by Sodium dodecyl sulphate – Polyacrylamide Gel Electrophoresis 
(SDS-PAGE). In SDS-PAGE the anionic detergent SDS binds to proteins, which mask the 
proteins’ intrinsic charge, resulting in a net negative charge (Garca-Descalzo, Garca-Lpez, 
Alczar, Baquero, & Ci, 2012). Complexes of SDS-protein thus migrate through the gel with 
a speed that is highly related to the protein’s molecular weight. In this study, lithium 
dodecyl sulphate (LDS) was used instead of SDS. Samples for SDS-PAGE were mixed 
with sample buffer that contain LDS and denatured by heating in water bath.  
 
Materials: 
10% Mini-PROTEAN® TGX Stain-Free™ Precast Gels, 10 or 15 wells 
BenchMark™ Unstained Protein Ladder 
MagicMark™ XP Western Protein Standard 
NuPAGE® LDS Sample Buffer (4X)  
NuPAGE® Sample Reducing Agent (10X) 
Gel Doc™ EZ imaging systems 
1X TGS Buffer 
Mini-PROTEAN Tetra Cell System, 4 gels 
PowerPac™ 300 
Water bath, 100°C 
 
Procedure: 
1. Make a 10 ml stock solution of 2X sample buffer and store at room temperature: 
- 5 ml 4X LDS Sample Buffer 
- 2 ml Reducing Agent 
- 3 ml dH2O 
2. Make SDS sample by mixing 2X sample buffer and protein sample in 1:1 ratio. 
Denature samples in 100°C water bath for 5 minutes.  
3. Prepare precast gels in Mini-PROTEAN Tetra Cell System and fill the electrophoresis 
chamber with 1X TGS buffer until the indicated mark.  
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4. Add 10 μl BenchMark™ ladder in one well.  
NB! Add or replace with 5 μl MagicMark™ ladder if the gel is going to be 
further analysed with Western blot. The amount MagicMark™ might have to be 
adjusted to optimal signal. 
5. Add 12 μl or 20 μl of sample per well for 15-wells and 10-wells gel, respectively.  
6. Run electrophoresis at 280 V for 18 minutes or expand run time till the dye band 
reaches the black line at the bottom of the gel. 
7. Place the gel on a stain-free tray and analyse with Gel Doc™ EZ imaging systems. 
8. If the gel is being further analysed with Western blot, wash gel in dH2O for 5 minutes 
before blotting (see section 3.4.2). 
3.5.3 Western.blot.analysis.
Western blot (immunoblotting) was used to detect the target protein. This is a 
method of immunodetection where proteins on a membrane surface (usually of 
nitrocellulose or polyvinylidene difluoride) can be detected through specific antigen-
antibody interactions. In this study antibody is conjugated with an enzyme label 
(horseradish peroxidase) that can oxidize a substrate to produce a detectable light-emission 
signal (chemiluminescence). To prevent unspecific binding of antibodies to unbounded 
sites, the blotted membrane needs to be blocked prior to incubation with antibodies. The 
following was done in this study: 
- SDS-PAGE was electrophoretically transferred to a nitrocellulose membrane. 
- The membrane was blocked with bovine serum albumin (BSA).  
- Indirect detection (figure 3.3) was performed, meaning that the enzyme label is attached 
to a secondary antibody that binds to the primary antibody.  
- For signal detection, the method of chemiluminescence with the substrate luminol and 
capture of light emission on film was employed (figure 3.3).   
 
Most of the Western blot analysis was performed with the SNAP i.d.® 2.0 instrument 
because Western blotting with this instrument is less time consuming. But in cases where 
higher specificity was desired, traditional Western blotting was performed. 
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Figure 3.3 Direct and indirect detection in Western blot (This figure was taken from “Western Blotting Handbook and 
Troubleshooting Tools, Version 3” 2010) 
 
Blotting.with.the.iBlot®.Dry.Blotting.System.
Materials: 
iBlot® Gel Transfer Device  
iBlot® Transfer Stacks Nitrocellulose Mini 
 iBlot® Cathode Stack, top 
 iBlot® Anode Stack, bottom 
 iBlot® Disposable sponge 
 iBlot® Filter paper 
Roller 
 
Procedure: 
1. Wash SDS-PAGE gel in dH2O for 5 minutes.  
2. Place the iBlot® Anode stack on the transfer device and place the gel upon the 
membrane. Roll out air bubbles between membrane and gel. Place a wet filter paper 
atop the gel and roll out air bubbles again. 
3. Place iBlot® Cathode Stack atop with the copper electrode side up. Roll one more time 
over the area.  
4. Place the disposable sponge as indicated inside the lid of the transfer device and close 
the lid.  
5. Perform blotting by applying 20 V for 7 minutes (program 3). Proceed to 
immunoblotting. 
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Western.blot.with.the.SNAP.i.d.®.2.0.Protein.Detection.System.
Materials: 
Bovine serum albumin (BSA), powder 
10X TBS or 10X PBS 
Tween 20 % 
Primary antibody  
Secondary antibody  
iBlot® Dry Blotting System 
SNAP i.d.® Protein Detection System 
Roller 
 
Table 3.1 Antibody dilutions used for the SNAP i.d.® 2.0 Protein Detection System 
 Dilution Incubation time 
Primary: 
Mouse-α-HspX 0.1 mg/ml 
Mouse-α-His 0.1 mg/ml  
 
1 : 2500 or 1 : 3000 
1 : 3000 
10 minutes 
   
Secondary:  
Polyclonal Rabbit Anti-Mouse 
Immunoglobulins/HRP 1.3 mg/ml 
 
1 : 5000 
10 minutes 
 
Procedure: 
1. To make 300 ml 0.1 % Tween-TBS or 1% Tween-PBS wash buffer: 
- 300 μl Tween 20% 
- 30 ml 10X TBS or 10X PBS 
- add dH2O to 300 ml 
2. To make antibody solution:  
- Transfer 40 ml wash buffer to a 50 Nunc tube and dissolve 0.2 g BSA in the wash 
buffer (= 0.5 % solution). 
- In two 15 ml Nunc tubes, transfer 3 ml of 0.5 % BSA/wash buffer to each. One is for 
the primary antibody, and the other is for the secondary antibody. 
3. To make 1% BSA blocking buffer: Pour off the 0.5 % BSA/wash buffer till there are 30 
ml left and dissolve 0.15 g BSA in the remaining 0.5% BSA/wash buffer. 
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4. Wet the membrane layer (white side) of the blot holder and place the membrane in the 
middle of the blot holder with the protein side down. Roll out air bubbles gently and 
close the blot holder, then roll one more time. 
5. Place the blot holder with the protein side up in the blot holder frame. Close and lock 
the frame on the SNAP i.d. 2.0 instrument.  
6. Add 30 ml blocking buffer and press down the frame and apply vacuum. Turn off the 
vacuum when the frame is completely empty. 
7. Add antibody solution and incubate for 10 minutes. Apply vacuum for 5-8 seconds after 
incubation and leave the vacuum on for washing. Wash three times with 10 ml wash 
buffer after each incubations. Add antibody almost right before incubation. 
8. Remove membrane from the blot holder and incubate with detection reagent. 
(Adapted from the SNAP i.d.® 2.0 Quick Start Guide 00114816 Rev. C manual) 
 
Traditional.Western.Blotting.
Materials: 
5 % skimmed milk/TBS or 5 % skimmed milk/PBS 
10X TBS or 10X PBS  
Tween 20 % 
Primary antibody  
Secondary antibody  
 
Table 3.2 Antibody dilutions and incubation time used for traditional Western blotting 
 Dilution Incubation time 
Primary: 
Mouse-α-HspX 0.1 mg/ml 
Mouse-α-His 0.1 mg/ml 
 
1 : 2500 or 1 : 3000 
1 : 3000 
60 minutes 
   
Secondary:  
Polyclonal Rabbit Anti-Mouse 
Immunoglobulins/HRP 1.3 mg/ml 
 
1 : 5000 
60 minutes 
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Procedure: 
1. To make 300 ml 0.1 % Tween-TBS or 1% Tween-PBS wash buffer: 
- 300 μl Tween 20% 
- 30 ml 10X TBS or 10X PBS 
- add dH2O to 300 ml 
2. To make blocking buffer: 
Transfer 40 ml wash buffer to a 50 Nunc tube and dissolve 2 g skimmed milk powder in 
the wash buffer to make a 5 % skimmed milk blocking buffer. 
3. To make antibody solution: 
In two 15 ml Nunc tubes, transfer 10 ml of the 5 % skimmed milk blocking buffer to 
each one. One is for the primary antibody, and the other is for the secondary antibody. 
On a benchtop shaker: 
4. Block membrane in 20 ml of the 5 % skimmed milk blocking buffer for 60 minutes on a 
benchtop shaker.  
5. Incubate with 10 ml primary antibody solution and incubate for 60 minutes at room 
temperature. Wash three times with 20 ml washing buffer.  
6. Incubate with 10 ml primary antibody solution and incubate for 60 minutes at room 
temperature. Wash three times with 20 ml washing buffer.  
7. Proceed to incubation with detection reagent. 
 
Detection.with.chemiluminescent.luminol.
Materials: 
SuperSignal® West Pico Chemiluminescent Substrate 
 Luminol/enhancer Solution 
 Stable Peroxide Solution 
CL-Xposure™ Film 
Developer 
Fixative 
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Procedure: 
1. Mix 5 ml of Luminol/enhancer Solution and 5 ml of Stable Peroxide Solution (1:1 
working solution) and incubate with antibody treated membrane for 5 minutes. Make 
sure that working solution covers the whole area of the membrane. 
2. After incubation, cover the membrane with plastic foil and avoid air bubbles. 
3. Place the membrane in a film cassette with the protein side facing up. 
4. Prepare developer and fixative in a dark room. 
5. Place a CL-Xposure™ Film on the membrane and close the film cassette. Expose for 
about 1 minute (up to 10 minutes depending on signal strength). 
6. Develop the exposed film for about 1-2 minutes. 
7. Fixate the developed film for at least 1 minute. 
8. Wash the film in dH2O and let it air-dry.  
(Adapted from the SuperSignal® West Pico Chemiluminescent Substrate manual from 
2014) 
 
Stripping.and.reprobing.of.Western.blots.
Materials: 
Restore™ Plus Western Blot Stripping Buffer 
1X TBS or 1X PBS wash buffer 
 
Procedure: 
1. Cover the membrane in a plastic foil or air-dry and stored at 4°C until stripping can be 
performed. 
2. Wash the membrane 2x5 minutes with wash buffer. 
3. Incubate the membrane in stripping buffer for 5-15 minutes at room temperature. 
4. Repeat step 2.  
(Adapted from the Restore™ Plus Western Blot Stripping Buffer instructions printed on 
bottle) 
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3.5.4 Flow.cytometry.analysis.and.immunofluorescent.detection.of.fusion.proteins.on.
cell.surface..
In this study, a secondary antibody coupled to fluorescein isothiocyanate (FITC) 
was used to detect a primary antibody bound to the target protein on the cell surface of L. 
plantarum WCFS. Fluorescent signals were then analysed with flow cytometry. In flow 
cytometry single cell particle can be detected. This is achieved by injecting sample into a 
core that is surrounded by an outer liquid sheath, and through hydrodynamic focusing, 
single particles in the core can pass through the detection system one by one (Rahman, 
2014). When a particle pass through the detection system, the surface properties of the 
particle can then be analysed through detection of light scattering and fluorescence 
emission. 
 
Materials: 
1X PBS 
2% BSA/PBS (w/v) 
Primary antibody: mouse-anti-HspX 
Anti-mouse IgG FITC-antibody 
Overnight culture of L. plantarum WFCS1 carrying plasmid 
 
Procedure: 
1. See section 3.2.1 for cultivation and section 3.3.1-3.3.3 for protein expression. 
2. Dilute the overnight culture of L. plantarum WCFS1 to OD=0.5 (approximately) 
3. Harvest 1 ml the diluted culture by centrifugation at 5000 x g for 3 minutes. Discard 
supernatant. 
4. Wash the cell pellet two times with 1 ml PBS and recollect cells by centrifugation at 
5000 x g for 2 minute. Aspirate supernatant after the last wash. 
5. Resuspend cell pellet in 50 μl 2 % BSA/PBS + 0.4 μl primary antibody and incubate for 
60 minutes at room temperature. 
6. After incubation, harvest the cells by centrifugation as in step 3. 
7. Wash the cell pellet three times with 1 ml 2 % BSA/PBS at 5000 x g for 2 minutes. 
Aspirate supernatant after the last wash. 
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8. Resuspend the cell pellet in 50 μl 2 % BSA/PBS + 0.2 μl secondary antibody and 
incubate for 30 minutes at room temperature in a dark environment. 
9. Repeat wash as in step 7. 
10. Store samples on ice and in a dark environment until analysis with a flow cytometer. 
11. Perform flow cytometry analysis with MacsQuant® Analyzer and MacsQuantify™ 
Software. Use the appropriate setting for detection of FITC signals on bacteria cells.  
 
. .
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3.7 Binding.assay.
The binding capacity of fusion proteins that contain LysM domain to Lactobacillus 
spp was investigated by incubating bacteria cells with cell-free protein extracts from the 
soluble fraction. After incubation, cells were washed and the presence of cell wall bound 
fusion proteins of interest was analysed with Western blot (section 3.4.3) or flow cytometry 
(section 3.4.4).  
 
Materials: 
Cell-free protein extract from soluble fraction  
Overnight culture or culture with cells harvested during the exponential phase: 
 L. plantarum WCFS1 
 L. rhamnosus GG 
 L. sakei Lb790 
1X PBS 
 
Procedure: 
1. Harvest cell by centrifugation at 5000 x g for 3 minutes. Discard supernatant. 
2. Wash the cell pellet two times with 1 ml PBS and recollect cells by centrifugation at 
5000 x g for 2 minute. Aspirate supernatant after the last wash. 
3. Resuspend the cells in PBS and dilute suspension to OD=0.5 (approximately) with 
PBS. 
4. Harvest cells from 1 ml of the cell suspension from step 3 by centrifugation at 5000 x g 
for 3 minutes. Discard supernatant.  
5. Resuspend and incubate cells with 1 ml cell-free protein extract (approx. 2 mg/ml). 
Incubate for 1 – 2 hours in room temperature with occasional mixing. 
6. After incubation, harvest the cell by centrifuge at 5000 x g for 3 minutes. Discard 
supernatant. 
7. Wash the cell pellet three times with 1 ml PBS and recollect cells by centrifugation at 
5000 x g for 2 minute. Aspirate supernatant after the last wash. 
8. Proceed to Western blot analysis (section 3.4.3) or flow cytometry (section 3.4.4) for 
detection protein. 
RESULTS   
 
62 
4 Results.
The M. tuberculosis fusion antigens used in this study were TB10.4 and HspX (TH). It 
had been shown that this combination is able to generate humoral and cell-mediated 
immune responses and has the potential as a multistage tuberculosis vaccine that provides 
protection against both active and latent infections (Niu et al., 2011). To promote targeting 
of dendritic cells, TH was coupled to a dendritic cell binding peptide (DC-seq), 
FYPSYHSTPQRP (Curiel et al., 2004), which was attached at the TH’s C-terminus.  
This study had two different non-GM approaches to produce and attach M. 
tuberculosis fusion antigens to Lactobacilli spp. In one of the non-GM approach, 
peptidoglycan binding LysM-anchors were N-terminally coupled to TH_DC-seq and the 
fusion proteins were produced intracellularly in E. coli. The binding ability of these LysM-
coupled fusion proteins to Lactobacillus spp was not tested due to challenges encountered 
during protein extraction. In the other non-GM approach, LysM_TH_DC-seq was produced 
intracellularly in and extracted from recombinant L. plantarum WCFS1, and the 
peptidoglycan binding ability to Lactobacillus spp was tested.  
In an alternative GM-approach, attempts were made to engineer recombinant L. 
plantarum WCFS1 to produce and display TH_DC-seq itself. In this GM-approach, three 
different anchors, a LysM-anchor, a lipobox-anchor and a LPxTG-anchor, were coupled to 
TH_DC-seq to enable anchoring. 
4.1 Intracellular.production.of.LysM[coupled.TH_DC[seq.in.E.coli.
4.1.1 Cloning.of.LysM.constructs.into.pET[16b.expression.vector.for.expression.in.E.#
coli#
The LysM domains used for intracellular production in E.coli, were derived from the 
genes lp_3014 and lp_2162 from L. plantarum WCFS1 (Zhou et al., 2010). Lp_3014 is a 
putative extracellular transglycosylase containing one LysM-domain at the N-terminus. 
Lp_2162 is a putative gamma-D-glutamate-meso-diaminoimelate muropeptidase with two 
LysM-domains at the N-terminus. These LysM-anchors were taken from existing pLp 
constructs (Table 2.4) and as outlined below. The genes of interest were cloned into pET-
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16b expression vector (Novagen, 2011) and transferred to chemically competent E.coli 
(section 3.2). Signal peptides were predicted with SignalP 4.1 Server 
(http://www.cbs.dtu.dk/services/SignalP/) and were excluded from the coding sequence to 
secure intracellular protein production. Note that pET-16b expression vectors produce a N-
terminal His-tag for protein purification with immobilized ion metal affinity 
chromatography (section 3.3.4), but this is not reflected in the plasmid names used in this 
study. 
TH_DC-seq was constructed, with the restriction sites SalI and EcoRI, in a 
commercial pUC plasmid from Genscript (Figure 4.1a). To couple TH_DC-seq with the 
full-length 3014-LysM from gene lp_3014 (see above and description in Table 2.3), 
TH_DC-seq was first subclone into the pre-existing pLp_3014_Inv (Fredriksen et al., 2012) 
as described in Figure 4.1b, resulting in pLp_3014_TH_DC-seq (all constructs constructed 
in this study are listed in Table 2.3).  
 
a  
 
b 
 
Figure 4.1 The TH_DC-seq insert from pUC and plasmid map of pLp_3014_TH_DC-seq (a) TH-DC-seq insert from 
pUC with the restriction sites SalI and EcoRI at the 5’-end and 3’-end of TH_DC-seq, respectively (b) Plasmid map of 
pLp_3014_TH_DC-seq. Inv was excised from pLp_3014_Inv with SalI and EcoRI and TH_DC-seq was then subcloned 
into the pLp vector resulting in pLp_3014_TH_DC-seq. 
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The insert, 3014_TH_DC-seq, was then subcloned into pET-16b with In-Fusion® 
cloning (section 3.2.5 and 3.2.8), resulting in pET16b_3014_TH_DC-seq (Figure 4.2a). To do 
this, fragment of the 3014_TH_DC-seq, with flanking NdeI and XhoI sites, were generated 
by PCR. The PCR-fragments were constructed to generate an overlap at their ends with the 
pET-16b plasmid vector. The forward and reverse primers used were pET 3014 F and pET 
Mtb.HspX_DC R, respectively (all primers used in this study are listed in Table 2.5 and 
Table 2.6). NdeI/XhoI-digested pET-16b plasmid vector and PCR-amplified insert gene of 
3014_TH_DC-seq was then recombined with the In-Fusion® Cloning Kit. To make 
pET16b_3014S_TH_DC-seq and pET16b_2162S_TH_DC-seq (Figure 4.2 b and c, Table 2.3 
), 3014S and 2162S were excised from NdeI/SalI-digested pET_3014S_AgESAT and 
pET_2162S_AgESAT (provided by Katarzyna Kuczkowska from the PEP research group 
at NMBU), respectively. The 3014S and 2162S are not the full-length sequence of lp_3014 
and lp_2162, and only encodes for the one and two LysM-domains derived from these 
genes (see above).   
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a 
 
b 
 
c 
 
 
Figure 4.2 Plasmid maps of pET-16b derivatives. (a) pET16b_3014_TH_DC-seq (b) pET16b_3014S_TH_DC-seq (c) 
pET16b_2162S_TH_DC-seq 
 
4.1.2 Making.control.constructs.with.the.pET[16b.expression.vector.
Of the three constructs made, pET16b_3014S_TH_DC-seq and 
pET16b_2162S_TH_DC-seq, encoding proteins with only the LysM domain(s), were 
targeted for further work and controls were constructed with that in mind. Control plasmids 
were generated using In-Fusion® Cloning Kit and PCR amplification with overlap 
extension, basically utilizing the same principal as in constructing pE16b_3014_TH_DC-
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seq described in section 4.1.1. In designing PCR-generated inserts, sequences encoding part 
of the fusion protein (e.g. LysM-anchors or DC-seq), were excluded. A total of four pET-
16b-based control constructs were made as listed below: 
Control constructs 
(description in Table 2.3) 
Primers  
(sequence and description in Table 2.5 and Table 2.6) 
pET16b_2162S_TH F: pET 2162 F 
R: pET Mtb.HspX R 
pET16b_3014S_TH F: pET 3014 F 
R: pET Mtb.HspX R 
pET16b_TH_DC-seq F: pET Mtb.HspX F 
R: pET Mtb.HspX_DC R 
pET16b_TH F: pET Mtb.HspX F 
R: pET Mtb.HspX R 
 
4.1.3 Intracellular.production.of.2162S_TH_DC[seq.in.E.#coli.and.purification.of.the.
protein.
Intracellular protein production in E.coli using pET-16b plasmids was induced with 
isopropyl β-D-1-thiogalactopyranoside (IPTG) (section 3.3.1). Bacterial cultures were 
lysed by sonication for 5 minutes with the amplitude of the probe set at 20%. Soluble and 
insoluble fraction of lysate was separated by centrifugation, and the soluble fraction was 
used in purification experiments with immobilized metal ion chromatography (IMAC) 
using Ni-NTA agarose beads (section 3.3.4). All the pET-16b plasmids carry a N-terminal 
His-tag as mentioned in section 4.1.1, and His-tagged proteins are expected to bind 
reversibly to immobilized Ni2+ ions on the Ni-NTA agarose beads packed in the column. 
Specific elution of His-tagged proteins can then be achieved by introducing a competing 
agent, in this case, a high concentration of imidazole. Flow-through of waste products was 
also collected for analysis. 
2162S_TH_DC-seq (44.90 kDa) was produced in E. coli harbouring the 
pET16b_2162S_TH_DC-seq plasmid by inducing with 0.4 mM IPTG and incubated at 
37°C for four hours. Analysis of the soluble and insoluble fraction of the cell lysate showed 
that production was strong, but all the protein appeared in the insoluble fraction, indicating 
that it was precipitated as insoluble inclusion bodies (Figure 4.3, lane 1 and 2). The soluble 
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fraction was used for protein purification by IMAC, which did not yield detectable amounts 
of protein (Figure 4.3, lane 3 and 4; the chromatogram gave no indication of purified 
proteins, data not shown). There were no bands that clearly indicated presence of target 
protein in the SDS-PAGE gel, and the protein was also not detectable by Western blot 
analysis of the eluate (data not shown). The buffers used in this attempt contained 20 mM 
imidazole in running buffer (Buffer A) and 100 mM imidazole in elution buffer (Buffer B).  
Based on this result, expressions of remaining pET-16b plasmids were set on hold 
and optimization experiments for production and purification of 2162S_TH_DC-seq was 
conducted (section 4.4.2). 
 
 
Figure 4.3 SDS-PAGE gel of protein extracts obtained from protein production and purification of 2162S_TH_DC-
seq (44.90 kDa) E. coli carrying pET16b_2162S_TH_DC-seq was induced with 0.4 mM IPTG and incubated at 37°C for 
four hours. Soluble fraction of protein extract was purified with IMAC. Lane 1 = Insoluble fraction of protein extract. 
Lane 2 = Soluble fraction of protein extract. Lane 3 = Flow-through from IMAC. Lane 4 = Eluate from IMAC. MW = 
molecular weight 
 
4.1.4 Optimization.experiments.for.the.production.and.purification.of.2162S_TH_DC[
seq.
In attempt to reduce formation of inclusion bodies in the production of 
2162S_TH_DC-seq, inductions at lower temperatures were tested. This strategy was 
inspired by Song et al. (2012) where the research team managed to overcome the 
insolubility problem of fusion proteins in E.coli by lowering the incubation temperature 
(Song, An, Kang, Lee, & Cha, 2012). Two incubation temperatures were tried: 10°C for 4-
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7 days; and 18°C overnight. The concentration of IPTG was also varied, where cultures 
were induced with 0.04 mM, 0.1 mM and 0.4 mM IPTG.  
Growing the cultures at 10°C seemed to increase the solubility at bit, but not substantially 
as the presence of the protein in the soluble fraction had to be confirmed with Western blot 
analysis (Figure 4.4 and Figure 4.5). Judging from the Western blot analysis, incubation at 
10°C for more than 4 days seemed to increase production of soluble protein, but more than 
5 days did not seem to make a substantial difference (Figure 4.5). 
 
 
Figure 4.4 SDS-PAGE gel of protein extracts obtained during optimization experiments for the production of 
2162S_TH_DC-seq (44.90 kDa) In all the cases except for lane 1, cells were induced with 0.4 mM IPTG. Lane 1 = 
soluble fraction obtained from uninduced culture grown at 10°C for 7 days. Lane 2&3 = 10°C for 4 days. Lane 4&5 = 
10°C for 5 days. Lane 6&7 = 10°C for 6 days. Lane 8&9 = 10°C for 7 days. Lane 10&11 = 18°C overnight. MW = 
molecular weight. S = soluble fraction, I = insoluble fraction. 
 
Figure 4.5 Western blot analysis of the soluble fraction of protein extracts obtained from optimization experiments 
for production of 2162S_TH_DC-seq (44.90 kDa) In all the cases, cells were induced with 0.4 mM IPTG. Mouse-α-His 
was used as the primary antibody. Lane 1 = 10°C for 4 days. Lane 2 = 10°C for 5 days. Lane 3 = 10°C for 6 days. Lane 4 
= 10°C for 7 days. Lane 5 = 18°C overnight. MW = Molecular weight. 
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The IPTG concentrations that yielded most soluble protein for incubation at 10°C 
and 18°C seemed to be 0.4 mM and 0.1 mM IPTG, respectively (Figure 4.6), but there was 
not a clear concentration-dependent pattern since it seemed that the base expression without 
inducer at 10°C was relatively strong as well (Figure 4.6, lane 4).  
 
 
Figure 4.6 Western blot analysis comparing IPTG concentrations and solubility of 2162S_TH_DC-seq (44.90 kDa) 
Samples are the soluble fraction of protein extracts obtained from optimization experiments for production of 
2162S_TH_DC-seq (44.90 kDa). Mouse-α-His was used as the primary antibody. Cultures grown at 10°C were incubated 
for  5 days (lane 1-4) and cultures grown at 18°C were incubated overnight (lane 5-8)were compared. Lane 1 = 0.4 mM. 
Lane 2 = 0.1 mM. Lane 3 = 0.04 mM. Lane 4 = uninduced. Lane 5 = 0.4 mM. Lane 6 = 0.1 mM. Lane 7 = 0.04 mM. Lane 
8 = uninduced. MW=molecular weight. 
 
Soluble fraction of protein extracts obtained from cultures grown at 10°C for 5 days 
and 18°C overnight, were purified. Purification was tried with lowering the imidazole 
concentration in running buffer to 0.5 mM imidazole and increasing the concentration to 
300 mM imidazole in elution buffer. Purification yield of 2162S_TH_DC-seq was still low. 
Band indicating the target protein in eluate was not seen in SDS-PAGE gel and only 
possibly detectable by Western blot analysis (Figure 4.7, lane 6 and 7).   
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a  
 
b 
                                         
Figure 4.7 SDS-PAGE gel and Western blot analysis of protein extract obtained from optimization experiments 
for purification of 2162S_TH_DC-seq (44.90 kDa) (a) Cultures grown at 10°C were incubated for 5 days and 
induced with 0.4 mM IPTG. Samples from soluble (lane 1) and insoluble fraction (lane 2) of protein extract were 
collected. Soluble fraction of protein extract was purified with IMAC and samples of flow-through (lane 5) and eluate 
(lane 6) were collected. Cultures grown at 18°C were incubated overnight and induced with 0.1 mM IPTG. Samples 
from soluble (lane 3) and insoluble fraction (lane 4) of protein extract were collected. Soluble fraction of protein 
extract was purified with IMAC and samples of flow-through (lane 7) and eluate (lane 8) were collected. (b) Western 
blot analysis of the same SDS-PAGE-gel. Mouse-α-His was used as the primary antibody MW = molecular weight. 
MM = Magic Mark MW standard for Western blot. S = soluble fraction, I = insoluble fraction. FT = flow through of 
IMAC purification. E = eluate of IMAC purification.  
 
There was an impurity in protein purification of 2162S_TH_DC-seq with a 
molecular weight of 70-80 kDa (Figure 4.7a, lane 6&8). Another member of the PEP group 
who used the same pET-16b system encountered a similar problem (similar non-expected 
band in protein electrophoresis), and mass-spectrometry analysis showed that this protein is 
catalase from E. coli.  
Due to no substantial increase of solubility, a tight time schedule and the impurity in 
purifications, the optimization experiment was terminated. The alternatives to produce 
proteins in L. plantarum WCFS1 (non-GM and GM approach) were prioritized. The 
remaining two pET-16b constructs for expression of LysM-tagged fusion antigens were not 
analysed further.   
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4.2 Intracellular.production.of.LysM[coupled.TH_DC[seq.in.L.#plantarum#WCFS1#.
4.2.1 Cloning.of.LysM.constructs.into.pLp.expression.vector.for.expression.in.L.#
plantarum#WCFS1.
The full-length sequence of the gene lp_3014 was used for intracellular production in 
L. plantarum WCFS1 (see section 4.1.1 for more detail, and all constructs made in this 
study are listed in Table 2.3). The plasmid was first made in E.coli (section 3.2.9) and 
plasmid DNA derived from E. coli was then isolated and transferred to L. plantarum 
WCFS1 by electroporation (section 3.2.11). The gene of interest were subcloned into a pLp 
expression vector, a derivative of the pSIP-400 series (Sørvig et al., 2003). The signal 
peptides was predicted with SignalP 4.1 Server (http://www.cbs.dtu.dk/services/SignalP/) 
and excluded from the coding sequence to secure intracellular protein production. pLp 
expression vectors do not have a sequence that encodes for a N-terminal His-tag for protein 
purification with IMAC (section 3.3.4). Thus, in this study, a N-terminal His6-tag was 
constructed for the pLp plasmid used for intracellular protein production in L. plantarum 
WCFS1. By utilizing the same principal as in constructing pE16b_3014_TH_DC-seq 
described in section 4.1.1, PCR amplification with vector-overlap extension and 
recombination with Fusion® Cloning Kit was done to construct pLp_His3014_TH_DC-seq 
(Figure 4.8). For this construct, the fragment encoding His3014_TH_DC-seq was generated 
by PCR-amplification. The PCR-fragment includes a self-made N-terminal His6-tag and 
overlap extension with the pLp vector, which includes the restriction sites NdeI and EcoRI. 
The forward and reverse primers used were pLp His3014uSP F and pLp TbH_DC R, 
respectively (table 2.5). NdeI/EcoRI-digested pLp_3014_TH_DC-seq (section 4.1.1 and 
Figure 4.1) was used as the vector. 
Attempts to construct a control, a pLp_HisTH_DC-seq plasmid that did not have the 
3014-LysM-anchor, was not successfully cloned to E. coli. Both In-Fusion® Cloning Kit 
and Quick Ligation™ Kit were tried and recombination with different ratio of vector and 
insert DNA was also varied, but none of the attempts were successful. 
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Figure 4.8 Plasmid mad of pLp_His3014_TH_DC-seq 
 
4.2.2 Intracellular.production.of.His3014_TH_DC[seq.in.L.#plantarum.WCFS1#
Expression of pLp_His3014_TH_DC-seq in L. plantarum WCFS1 was induced with 
25 ng/ml peptide pheromone SppIP (section 3.3.2). Bacterial culture was incubated at 30°C 
for five hours and lysed by sonication for 15 minutes with the amplitude of the probe set at 
30%.  
His3014_TH_DC-seq (48.51 kDa) was produced and the presence of the protein in 
the soluble fraction of protein extract could be detected by Western blot analysis with 
antibodies specific to HspX (α-HspX) and histidine (α-His) (Figure 4.9). Western blot 
showed that production of His3014_TH_DC-seq gave a band with bigger molecular weight 
(ca. 60 kDa) than what was predicted (48.51 kDa) in-silico (Figure 4.9). This size 
discrepancy was also observed in production of 3014_TH_DC-seq (section 4.4.2; the GM-
approach). A band in SDS-PAGE gel of the insoluble fraction of protein extract indicated 
that some of the protein was precipitated, but this was not confirmed with Western blot 
(Figure 4.10). Comparing the insoluble fractions of protein extract in Figure 4.10 and 
Figure 4.1, expression level of pLp_His3014_TH_DC-seq obtained upon intracellular 
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expression in L. plantarum WCFS1, was substantially lower than that of intracellular 
expression of pET16b_2162S_TH_DC-seq in E. coli.  
 
  
Figure 4.9 Western blot analysis of the soluble fraction of protein extract obtained from production of 
His3014_TH_DC-seq (48.51 kDa) with pLp vector in L. plantarum WCFS1 Expression of His3014_TH_DC-seq with 
pLp plasmid in L. plantarum WCFS1 gave size discrepancy (ca. 60 kDa). MW = Molecular weight. N = negative control. 
P = positive control (44.90 kDa). Lane 1 = His3014_TH_DC-seq. 
 
 
Figure 4.10 SDS-PAGE gel of the soluble and insoluble fraction of protein extract obtained from production 
His3014_TH_DC-seq with pLp plasmid in L. plantarum WCFS1 Expression of His3014_TH_DC-seq with pLp 
plasmid in L. plantarum WCFS1 gave size discrepancy (ca. 60 kDa). MW = molecular weight. S = soluble fraction. I = 
insoluble fraction 
 
Longer induction times seemed to increase the yield, but the differences were not 
substantial (Figure 4.11). The Western blot analyses were carried out with both α-HspX 
and α-His, and the same pattern was seen. Cells in Figure 4.11 were in this case treated 
with glass beads and lysed with FastPrep®-24 homogenizer and not by sonication. 
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Figure 4.11 Western blot analysis comparing induction times of intracellular production of His3014_TH_DC-seq 
(48.51 kDa) in L. plantarum pLp_His3014_TH_DC-seq was expressed in L. plantarum WCFS1 induced with 25 ng/ml 
SppIP and incubated at 30°C for 2-5 hours. Samples are the soluble fractions of protein extract from cells lysed with glass 
beads treatment, using a FastPrep®-24 homogenizer. Mouse-α-HspX was used as the primary antibody. Expression of 
His3014_TH_DC-seq with pLp plasmid in L. plantarum WCFS1 gave size discrepancy (ca. 60 kDa). MW = molecular 
weight. N = negative control, P = positive control (44.90 kDa). 
 
4.2.3 Purification.of.His3014_TH_DC[seq.from.the.soluble.fraction.of.protein.extract.
His3014_TH_DC-seq was produced in L. plantarum WCFS1 carrying the plasmid 
pLp_His3014_TH_DC-seq as described in section 4.2.2 and the soluble fraction of protein 
extract was purified with IMAC (section 3.3.4). The imidazole concentrations used in 
running buffer and elution buffer were 0.5 mM and 300 mM, respectively. As mentioned in 
section 4.2.1, pLp vectors do not contain a sequence that encodes for a N-terminal His-tag. 
Thus, to purify His3014_TH_DC-seq with IMAC, this protein contains an in-house 
constructed N-terminal His6-tag (theory explained in section 3.3.4 and section 4.1.3). Flow-
through of waste products was also collected for analysis. 
Purification of His3014_TH_DC-seq did not yield detectable amounts of protein. 
The chromatogram gave no indication of purified proteins (data not shown). No band 
indicating the presence of the target protein in SDS-PAGE gel and Western blot analysis of 
the eluate was observed (Figure 4.12; note that the Western blot analysis was not blotted 
from the same SDS-PAGE gel from Figure 4.12, but the same samples were used for both 
the SDS-PAGE gel and the Western blot analysis).  
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Due to little time left for this study, further purification experiments were not 
conducted. Instead, His3014_TH_DC-seq from the soluble fraction of protein extract was 
used to test the fusion protein’s binding ability to L. plantarum WCFS1.  
 
a 
 
b 
 
Figure 4.12 Purification of His3014_TH_DC-seq (48.51 kDa) from soluble fraction of protein extract (a) SDS-
PAGE gel showing protein contents from soluble fraction of protein extract, flow-through and eluate from IMAC.(b) 
Western blot analysis of purification from soluble fraction of protein extract. Mouse-α-HspX was used as the primary 
antibody. Expression of His3014_TH_DC-seq with pLp plasmid in L. plantarum WCFS1 gave size discrepancy (ca. 
60 kDa).  
 
4.3 Testing.the.binding.ability.of.His3014_TH_DC[seq.to.the.surface.of.
Lactobacillus.spp.
The soluble fraction of protein extract obtained by sonication cell lysis of L. 
plantarum WCFS1 cells, and that contained the fusion protein His3014_TH_DC-seq was 
used to test the binding ability of the protein to the cell surface of L. plantarum WCFS1, 
Lactobacillus sakei Lb790 and Lactobacillus rhamnosus GG. L. plantarum WCFS1, L. 
sakei Lb790 and L. rhamnosus GG was cultivated overnight in 10 ml MRS medium at 
30°C. Bacterial cultures were diluted with wash buffer (PBS) to approximately OD = 0.5 
and cells from the diluted suspension were harvested and incubated with the soluble 
fraction of protein extract (≈2 mg/ml) containing His3014_TH_DC-seq, for one hour 
(section 3.5). In this set up, a control extract of a fusion protein that lacks the LysM-anchor, 
was not included.  
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After incubation, cells were washed with PBS for excess unbound proteins and 
analysed with Western blot using α-HspX to analyse for the presence of binding of 
His3014_TH_DC-seq to Lactobacillus spp. The Western blot showed the target band 
indicating the presence of His3014_TH_DC-seq (Figure 4.13).  
 
 
Figure 4.13 Western blot analysis analysing the binding of His3014_TH_DC-seq to the cell surface of Lactobacillus 
spp The soluble fraction of protein extract containing His3014_TH_DC-seq was obtained form lysis of recombinant L. 
plantarum WCFS1 and incubated with L. plantarum WCFS1 (lane 1), L. rhamnosus GG (lane 2) and L. sakei Lb790 (lane 
3) for one hour. Mouse-α-HspX was used as the primary antibody. Expression of His3014_TH_DC-seq with pLp plasmid 
in L. plantarum WCFS1 gave size discrepancy (ca. 60 kDa).MW = molecular weight. 
 
To analyse the presence of binding of His3014_TH_DC-seq to Lactobacillus spp 
without lysing the cells, flow cytometry analysis (section 3.4.4) was done to detect surface 
display of His3014_TH_DC-seq on live Lactobacillus spp. The primary and secondary 
antibody used was α-HspX and anti-mouse IgG FITC, respectively. The soluble fraction of 
protein extract obtained from expression of a pLp construct that did not have any insert 
gene (pEV), was also incubated with Lactobacillus spp and used as a negative control for 
α-HspX’s specificity in flow cytometry, which would be the background signal. Cells 
obtained from expression of pLp_3014_TH_DC-seq which directly displays 
3014_TH_DC-seq on the cell surface of recombinant L. plantarum WCFS1 (section 4.4.2; 
the GM-approach), was tested at the same time. This was due to lack of a positive control 
for flow cytometry analysis using α-HspX in the laboratory for PEP research group. Since 
this construct constitutively displays the 3014_TH_DC-seq on the cell surface, it would in 
theory, give signals that are markedly above the background signal in flow cytometry 
analysis with α-HspX. No positive signals could be detected with flow cytometry, with 
signals from L. sakei Lb790 cells incubated with protein extract containing 
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His3014_TH_DC-seq or the negative control being unusually low (Figure 4.14, note that 
signals of the theoretically positive control in histogram for L. sakei Lb790 is the same as in 
the histograms for L. plantarum WCFS1 and L. rhamnosus GG).  
 
 
L. plantarum WCFS1 
 
L. sakei Lb790 
 
L. rhamnosus GG 
 
 
 
 
Figure 4.14 Histograms of flow cytometry analysis of the binding of His3014_TH_DC-seq to Lactobacillus spp. 
Cells (L. plantarum WCFS1, L. sakei Lb790 and L. rhamnosus GG) were incubated with soluble fraction of protein 
extract containing His3014_TH_DC-seq (green) or that did not have any insert gene (pEV, black). Cells constitutively 
displaying 3014_TH_DC-seq (blue) were also tested as a positive control. Mouse-α-HspX was used as the primary 
antibody. NB! Note that signals from positive control in the histogram for L. sakei Lb790 is the same as in the other 
histograms. 
 
4.3.1 Further.analysis.of.His3014_TH_DC[seq’s.binding.ability.to.L..plantarum.WCFS1.
using.Western.blot.analysis.
Further experiments to test the binding ability of His3014_TH_DC-seq to the cell 
surface of L. plantarum WCFS1 was done. The efficacy of binding at stationary and 
exponential phase was tested, and the efficacy of binding with incubation for one and two 
hours was also tested. Two independent cultivations of L. plantarum WCFS1 were done in 
parallel to repeat the experiment. L. plantarum WCFS1 cells were harvested as described in 
section 4.3 and incubated with soluble fraction of protein extract (≈2 mg/ml) containing 
His3014_TH_DC-seq.  
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Comparison of the binding ability of fusion proteins with and without the 3014-
LysM-anchor to the cell surface of L. plantarum WCFS1 was also experimented. Since 
attempts made to construct the control plasmid pLp_HisTH_DC-seq was not successful as 
described in section 4.2.1, soluble fraction of protein extract containing TH_DC-seq (30.99 
kDa) obtained from expression of pET_TH_DC-seq (Table 2.3 and section 4.1.2) in E.coli 
was used. pET_TH_DC-seq was expressed in E. coli, induced with 0.1 mM IPTG and 
incubated overnight at 37°C. L. plantarum WCFS1 cells were harvested as described in 
section 4.3 and incubated with soluble fraction of protein extract (≈3.6 mg/ml) containing 
TH_DC-seq. After incubation with L. plantarum WCFS1, the cells were washed with PBS 
for excess unbound proteins and analysed with Western blot using α-HspX to analyse for 
the presence of binding of His3014_TH_DC-seq and TH_DC-seq to L. plantarum WCFS1.  
Western blot analysis showed target band in both incubation with His3014_TH_DC-
seq and TH_DC-seq (Figure 4.15). Binding was indicated in both stationary and 
exponential phase, and after both one and two hours of incubation. Due to little time left in 
this study, these experiments were not tested with L. sakei Lb790 and L. rhamnosus GG.  
 
  
Figure 4.15 Western blot analysis of the binding ability of His3014_TH_DC-seq and TH_DC-seq to L. plantarum 
WCFS1 L. plantarum WCFS1 cells were incubated with His3014_TH_DC-seq (48.51 kDa) or TH_DC-seq (30.99 kDa) 
obtained from the soluble fraction of protein extract from production in L. plantarum WCFS1 and E. coli, respectively. 
Incubation for one (1) and two (2) hours was done with cells from stationary (s) and exponential (e) phase. Two 
independent cultivations (A and B) were done in parallel to repeat the experiment. Mouse--HspX was used as the 
primary antibody. Expression of His3014_TH_DC-seq with pLp plasmid in L. plantarum WCFS1 gave size discrepancy 
(ca. 60 kDa). MW = molecular weight.  
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4.3.2 Further.analysis.of.His3014_TH_DC[seq’s.binding.ability.to.L..plantarum.WCFS1.
using.flow.cytometry.
The binding ability of His3014_TH_DC-seq and TH_DC-seq to L. plantarum 
WCFS1 was also analysed with flow cytometry using α-HspX and anti-mouse IgG FITC as 
the primary and secondary antibody, respectively. In these experiments, set-ups only 
included cells from stationary phase that were incubated for one hour and two independent 
cultivations of L. plantarum WCFS1 were done in parallel to repeat the experiment. The 
concentrations used of the soluble fraction of the protein extracts are as described in section 
4.3.1. The soluble fraction of protein extract obtained from expression of a pLp construct 
that did not have any insert gene (pEV), was also incubated with L. plantarum WCFS1 and 
used as a negative control for α-HspX’s specificity in flow cytometry, which would be the 
background signal. Because of difficulty obtaining positive signals, different dilutions of 
primary (α-HspX) and secondary antibody (anti-mouse IgG FITC) were tested as listed 
below:  
 
Set-up α-HspX  anti-mouse IgG FITC  
F1 1:125 1:125 
F2 1:125  1:250 
F3 1:50 1:250 
 
Surprisingly, only incubation with TH_DC-seq gave positive signals and at all the 
three different antibody set-ups (Figure 4.16).  
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F1 
  
F2  
 
F3 
  
 
 
 
 
 α-HspX  anti-mouse IgG FITC  
F1 1:125 1:125 
F2 1:125  1:250 
F3 1:50 1:250 
 
Figure 4.16 Histograms of flow cytometry analyses of the binding ability of His3014_TH_DC-seq and TH_DC-seq 
to L. plantarum WCFS1 L. plantarum WCFS1 cells were incubated with the soluble fraction of protein extract 
containing His3014_TH_DC-seq (green), TH_DC-seq (blue) or that did not have any insert gene (pEV, black). . Mouse-
α-HspX was used as the primary antibody. The table shows the different dilutions of antibodies used in the set-ups F1, F2 
and F3. 
 
. .
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4.5 Direct.display.of.TH_DC[seq.on.the.cell.surface.of.recombinant.L.#plantarum#
WCFS1..
4.5.1 Cloning.constructs.into.pLp.expression.vector.for.expression.in.L.#plantarum.
WCFS1.
Due to problems with protein purification, an alternative GM-approach was 
commenced. In this GM-approach (as explained in introduction of section 4), TH_DC-seq 
was coupled to three different anchors derived from the genes of L. plantarum WCFS1: a 
N-terminal LysM-anchor derived from lp_3014 encoding for a putative extracellular 
transglycosylase; a N-terminal lipobox-anchor derived from lp_1261encoding for a 
substrate binding oligopeptide ABC transporter; and a C-terminal LPxTG-anchor derived 
from lp_2578 encoding for a collagen-binding adherence protein (Zhou et al., 2010). The 
GM-approach was to produce TH_DC-seq using pLp expression vector and display 
TH_DC-seq directly on the cell surface of recombinant L. plantarum WCFS1. As 
proceeded in section 4.2, constructs were first made in E.coli (section 3.2.9) and plasmid 
DNA derived from E. coli were then isolated and transferred to L. plantarum WCFS1 by 
electroporation (section 3.2.11).  
The construct pLp_3014_TH_DC-seq, was already made as described in section 4.1.1 
and Figure 4.1b (all constructs constructed in this study are listen in Table 2.3). The 
construct pLp_1261_TH_DC-seq (Figure 4.17a) was made by excising TH_DC-seq from 
pLp_3014_TH_DC-seq using SalI and EcoRI and subcloned into SalI/EcoRI-digested 
pLp_1261_Inv (Fredriksen et al., 2012). For the pLp_0373_TH_DC-seq_2578 construct 
(Figure 4.17b), In-Fusion® cloning (section 3.2.5 and 3.2.8) was done due to the lack of an 
MluI site, which is normally used for swapping C-terminal anchors in the pSIP400 vectors 
(in which pLp is a derivative of), in the TH_DC-seq sequence. A PCR-generated fragment 
encoding TH_DC-seq with flanking SalI and MluI sites was made and recombined with 
SalI/MluI-digested pLp_0373_OFA_cwa2 (Fredriksen et al., 2010). The forward and 
reverse primers used for generating the fragment were pLp 0373_TbH_DC F and pLp 
TH_DC_cwa2 R, respectively (table 2.5). 0373 refers to the N-terminal signal peptide used 
in this construct and is derived from gene lp_0373 from L. plantarum WCFS1 that encodes 
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for a cell surface protein precursor and which also contain a LPxTG-anchor (Zhou et al., 
2010). 
 
 
a 
 
b 
 
Figure 4.17 Plasmid maps of pLp constructs  in the GM approach (a) pLp_1261_TH_DC-seq (b) pLp_0373_TH_DC-
seq_2578. 
 
4.5.2 Direct.display.of.TH_DC[seq.on.cell.surface.of.L.#plantarum#WCFS1..
For this GM-approach, TH and DC-seq was fused with anchors, cloned into pLp 
expression vector and expressed directly on cell surface of L. plantarum WFCS1. TH_DC-
seq was fused with three different anchors (see above in section 4.4.1) making the fusion 
proteins 3014_TH_DC-seq (LysM-anchor), 0373_TH_DC-seq_2578 (LPxTG-anchor) and 
1261_TH_DC-seq (lipobox-anchor). Intracellular production of fusion proteins in L. 
plantarum WCFS1 using pLp expression vector was induced with 25 ng/ml peptide 
pheromone SppIP for 2-5 hours. Induced bacterial culture was then lysed with glass beads 
treatment and FastPrep®24 homogenizer.  
No strongly indicative band of target proteins in SDS-PAGE gel was observed for all of 
the three fusion proteins (Figure 4.18). But production could be detected by Western blot 
analysis using α-HspX (Figure 4.19) with the exception of 0373_TH_DC-seq_2578 that 
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has the LPxTG-anchor. Western blot also showed that production of 3014_TH_DC-seq 
gave a band with bigger molecular weight (ca. 60kDa), than what was predicted (49.98 
kDa) in-silico. This size discrepancy was also the case in intracellular production of 
His3014_TH_DC-seq (48.51 kDa) (section 4.5.1, non-GM approach using pLp vector and 
L. plantarum WCFS1). 
Flow cytometry (section 3.4.4) was done to confirm cell-surface display of fusion 
proteins, but no positive signals were detected from any of the constructs (data not shown). 
α-HspX and anti-mouse IgG FITC were used as the primary and secondary antibody, 
respectively. And the dilution for both antibodies was 1:125. Due to lack of time, no further 
experiments were done for the alternative GM-strategy. 
 
  
Figure 4.18 SDS-PAGE gel of soluble fraction of protein extract of fusion proteins obtained from production in L. 
plantarum WCFS1 SDS-PAGE analysis of protein production of 0373_TH_DC-seq_2578 (55.29 kDa, LPxTG-anchor), 
1261_TH_DC-seq (36.82 kDa, lipobox-anchor), 3014_TH_DC-seq (49.98 kDa, LysM-anchor) and His3014_TH_DC-seq 
(48.51 kDa, LysM-anchor and with N-terminal His6-tag). Incubation for 2-5 hours. Expression of His3014_TH_DC-seq 
with pLp plasmid in L. plantarum WCFS1 gave size discrepancy (ca. 60 kDa). MW = molecular weight.  
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Figure 4.19 Western blot analysis of protein production in the L. plantarum WCFS1 for the GM-strategy TH_DC-
seq was fused with three different anchors making (1) pLp_0373_TH_DC-seq_2578 (55.29 kDa, LPxTG-anchor), (2) 
pLp_1261_TH_DC-seq (36.82 kDa, lipobox-anchor) and (3) 3014_TH_DC-seq (49.98 kDa, LysM-anchor). Expression of 
His3014_TH_DC-seq with pLp plasmid in L. plantarum WCFS1 gave size discrepancy (ca. 60 kDa). MW = molecular 
weight. 
 
  DISCUSSION 
 
 85 
5 Discussion.
5.1 Intracellular.production.and.purification.of.LysM[coupled.fusion.proteins.
Overproduction of heterologous proteins in E. coli is one of the most commonly 
applied strategies. This is due to E. coli’s well studied genome, fast growth rate, high cell 
density production as well as the ease and low price of cultivation (Peternel, 2013). In this 
study it has been shown that it is possible to use the pET-16b expression vector for 
production of the M. tuberculosis fusion antigen TB10.4-HspX (TH). This was shown with 
the fusion protein 2162S_TH_DC-seq, where TH was coupled N-terminally to the 2162-
LysM anchor that has two LysM-domains, and C-terminally to a dendritic cell binding 
peptide sequence (DC-seq). The 2162-LysM anchor is derived from the gene lp_2162 from 
L. plantarum WCFS1 that codes for a putative gamma-D-glutamate-meso-diaminoimelate 
muropeptidase (section 1.5.1). The production of 2162S_TH_DC-seq was confirmed by a 
strong band in SDS-PAGE (Figure 4.3 and Figure 4.4) and immunodetection with Western 
blot analysis (Figure 4.7). However, the target protein was mostly found in the insoluble 
fraction of the protein extract, indicating that 2162S_TH_DC-seq aggregated in insoluble 
inclusion bodies (IBs). The high production level is often found to be stressful for the host 
and aggregates of target protein in IBs are common in overexpression of fusion proteins 
(Peternel, 2013). Reducing the expression rate could be useful, thus cultivations at lower 
temperatures and varying the inducer concentration was done in attempt to improve the 
solubility of 2162S_TH_DC-seq, but this only resulted in marginal improvement. Due to 
this negative result and considering other available options, the remaining LysM-containing 
pET-16b constructs were not used for further work in this study.  
Previous studies have shown that it is possible to induce immune responses from 
antigens extracted from IBs that have been solubilized for purification and refolded before 
administrations to animal test model (Kesik, Saczyńska, Szewczyk, & Płucienniczak, 2004; 
Leal et al., 2006). Based on the results from purification of 2162S_TH_DC-seq from the 
soluble fraction done in this study, this alternative is already being explored in the PEP 
research group at NMBU. 
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Modifications of the construction of 2162S_TH_DC-seq is another strategy that 
could have been tested as small changes in the primary structure of the protein, such as 
insertion of linker peptide sequence in between genes/domains of interests, could be 
enough to shift the solubility of the protein (Peternel, 2013). This was not experimented in 
this study, but might be worth experimenting in future studies as successful shift towards 
better solubility of fusion proteins can avoid the burdensome procedures of solubilizing IBs 
for purification and the procedures of refolding of these solubilized aggregated proteins. It 
has in recent years been shown that a substantial amount of properly folded proteins can be 
found trapped inside IBs produced at lower growth temperatures, and that these proteins 
can easily be released from IBs using mild detergents under non-denaturing conditions 
(Peternel, Grdadolnik, Gaberc-Porekar, & Komel, 2008). This strategy could also be worth 
experimenting as this strategy too avoids the burdensome procedures of denaturing and 
refolding proteins. 
As there was no substantial improvement of the solubility of 2162S_TH_DC-seq, 
the alternative strategy to use pLp expression vector in L. plantarum WCFS1 for another 
non-GM approach were prioritized. The pLp expression vector is a derivative of p400-
series of the pSIP system (Sørvig et al., 2003) It has previously been shown that it is 
possible to produce heterologous proteins with over 50% dominance of the intracellular 
protein content using pLp expression vector in L. plantarum WCFS1 (Mathiesen et al., 
2004; Nguyen et al., 2012). Thus, expression in L. plantarum WCFS1 using a pLp was 
explored in this other non-GM approach, using His3014_TH_DC-seq as the target protein. 
3014 denotes the full-length peptide sequence derived from gene lp_3014 that contains one 
N-terminal LysM-domain and includes the transglycosylase peptide sequence (section 
1.5.1; the N-terminal signal peptide was excluded for intracellular production). A His6-tag 
was fused N-terminally to enable purification with immobilized metal ion affinity 
chromatography (IMAC), as pLp vectors do not contain any polyhistidine coding sequence. 
The production yield of His3014_TH_DC-seq was low. The SDS-PAGE gel gave no 
indication of overproduction of the target protein (Figure 4.10). In general, protein 
production using pLp expression system in L. plantarum WCFS1 was low in this study, as 
the production of fusion proteins in the GM-approach was low as well (see further below). 
This indicates that the derivative pLp plasmid from the pSIP400-series is not suitable for 
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overexpression of TH_DC-seq, TH or DC-seq. Anchors used in this study were all derived 
from L. plantarum WCFS1 and have been used in successful expression before (Tjåland, 
2011), so it seemed less possible that these anchors were causing the low production yields. 
However, the coupling of these anchors to TH_DC-seq, TH or DC-seq might have affected 
the production yield too.  
In this study, the purification method used was to fuse N-terminal polyhistidine-tag 
to the fusion proteins and purify with IMAC (theory in section 3.3.4). Ni-NTA beads were 
preloaded onto column before loading of protein sample. The target proteins 
(2162S_TH_DC-seq and His3014_TH_DC-seq) could be detected by immunodetection 
with Western blot analysis. However, the target proteins were only detected in the soluble 
fraction of the protein extract and in the flow-trough of waste products from IMAC, but not 
in the purification eluates. This indicates inefficient binding between His-tag and Ni2+ ions 
and that the purification procedure might need to be optimized to extract the target protein 
from the soluble fraction. Incubating Ni-NTA beads with the protein sample before loading 
onto column, might result in more efficient binding of tagged protein to Ni2+ ions in Ni-
NTA beads (Bornhorst & Falke, 2000). It should also be noted that the protein yield in the 
soluble fraction was low, making purification more challenging since it would require 
higher affinity of His-tagged proteins for Ni2+ ions to be sufficiently effective for 
purification. Concentration of protein in eluate might also result in detectable amount in 
SDS-PAGE gel and Western blot analysis.  
A size discrepancy was observed in Western blot analysis of His3014_TH_DC-seq 
produced in L. plantarum WCFS1 using a pLp vector (section 4.2.2). The Western blot 
analysis showed a band with bigger molecular weight (ca. 60 kDa) than what was predicted 
(48.51 kDa) in silico. This may be caused by the combination of fusing 3014 with TH_DC-
seq. The fact that production of the other fusion proteins did not showed this anomaly, 
except of the production of 3014_TH_DC-seq that also showed the same size discrepancy 
in Western blot analysis (section 4.4.1; the GM-strategy), support this hypothesis.  
5.1.1 Binding.of.His3014_TH_DC[seq.to.Lactobacillus.spp..
In this study, the peptidoglycan binding ability of the 3014-LysM domain (section 
1.5.1), coupled to the fusion protein TH_DC-seq, has been tested. Due to unsuccessful 
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purification with IMAC, purified eluate was not obtained in this study. Thus, the soluble 
fraction of protein extract containing the target protein was used for the binding assays. The 
plasmid pLp_His3014_TH_DC-seq was used for expression in L. plantarum WCFS1 and 
the soluble fraction of the protein extract containing His3014_TH_DC-seq was used for the 
binding assays. Cells of L. plantarum WCFS1, L. sakei Lb790 and L. rhamnosus GG were 
incubated, at room temperature, with protein extract containing His3014_TH_DC-seq. 
After incubation the cells were washed for excess unbound proteins and the cells were 
analysed with Western blot analysis for the presence of the proteins in which bindings 
seemed to had occurred (section 4.3 and Figure 4.13). Although binding seemed to have 
occurred between His3014_TH_DC-seq and the Lactobacillus spp, this was not 
confidentially confirmed. This is because a soluble fraction of protein extract that did not 
contain a TH_DC-seq that lacks the 3014-LysM anchor, was not included in this 
experiment. Thus, there were no controls that could support the indication of binding of 
His3014_TH_DC-seq to the cell surface of L. plantarum WCFS1, L. sakei Lb790 and L. 
rhamnosus GG. Without controls in the set-ups, it was not possible to verify that specific 
bands from Western blot analysis were actually due to binding between His3014_TH_DC-
seq and the cell surface of Lactobacillus spp, and not due to technical issues such as 
insufficient washing of excess unbound proteins. Even if the observation of target bands 
were due to binding between the fusion protein and the cells, without a control that lacks 
the 3014-LysM, it was not possible to verify that it is actually the LysM that causes the 
binding. Attempts made to detect His3014_TH_DC-seq on the cell surface of live L. 
plantarum WCFS1, L. sakei Lb790 and L. rhamnosus GG by using flow cytometry analysis 
were not successful (section 4.3 and further discussed below). 
The binding ability of His3014_TH_DC-seq was further investigated using only L. 
plantarum WCFS1. In these experiments, the soluble fraction of protein extract from E. coli 
containing TH_DC-seq (i.e. without the 3014-LysM) was also incubated with L. plantarum 
WCFS1. The fusion protein TH_DC-seq needed to be expressed from the plasmid pET16b-
TH_DC-seq in E.coli because attempts made to construct a control with the pLp vector 
were unsuccessful (section 4.2.1). In the further experimentations, L. plantarum WCFS1 
cells from stationary and exponential phase was incubated at room temperature, with the 
soluble fractions of protein extract containing His3014_TH_DC-seq and TH_DC-seq for 
  DISCUSSION 
 
 89 
one and two hours. The results from Western blot analysis indicate that both 
His3014_TH_DC-seq and TH_DC-seq are able to bind to L. plantarum WCFS1 and that 
the binding efficacy is the same for cells in stationary and exponential phase (Figure 4.15). 
Incubation for one and two hours did not seem to result in any differences in binding 
efficacy for both His3014_TH_DC-seq and TH_DC-seq. These observations indicate that 
binding was stable with incubation at room temperature for up to two hours, but that two 
hours of incubation time did not seem to improve the binding efficacy. Other reasons such 
as saturated binding capacity due to insufficient amount of cells to bind to the proteins or 
vice versa, might also be the reason why a difference in binding capacity was not observed 
between one and two hours of incubation. This could have been investigated by varying the 
amount of cells or the soluble fractions of the protein extract used in incubation for one and 
two hours. The Western blot analysis of the binding ability of the fusion proteins to L. 
plantarum WCFS1 in Figure 4.15 gave stronger bands with cells incubated with TH_DC-
seq than cells incubated with His3014_TH_DC-seq. This could be due to different reasons 
such as: that TH_DC-seq binds stronger than His3014_TH_DC-seq; binding is independent 
of 3014-LysM and that 3014-LysM hinder binding; abundance of TH_DC-seq was higher 
than His3014_TH_DC-seq in the soluble fraction of protein extract; and that the HspX-
epitope in His3014_TH_DC-seq is less accessible for α-HspX. 
To detect binding of His3014_TH_DC-seq and TH_DC-seq to the cell surface of 
live L. plantarum WCFS1, flow cytometry analysis was also carried out. Due to difficulties 
in obtaining positive signals, different dilutions of primary and secondary antibody were 
tested using three different set-ups (section 4.3.2). Surprisingly, only incubation with 
TH_DC-seq gave positive signals and at all the three different antibody set-ups (Figure 
4.16). This observation could have the same causes as those listed above for the Western 
blot analysis. The amount of His3014_TH_DC-seq may have been too small and therefore 
under the detection limit of flow cytometry. Another possible explanation is that the HspX-
epitope might not have been accessible for α-HspX when used in flow-cytometry since 
fusion proteins are detected in their native form in flow cytometry, in contrast to Western 
blot analysis where the fusion proteins are denatured for detection.  
The results from assays of the binding ability of His3014_TH_DC-seq and TH_DC-
seq to the cell surface of Lactobacillus spp, indicate binding of His3014_TH_DC-seq to L. 
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plantarum WCFS1, L. sakei Lb790 and L. rhamnosus. However, further experiments 
showed that TH_DC-seq is also able to bind to L. plantarum WCFS1, and might even have 
a stronger affinity for L. plantarum WCFS1 than His3014_TH_DC-seq. The data thus seem 
to suggest that LysM domain is not involve in binding of TH_DC-seq, but clearly, more 
work is needed to substantiate this indication. Ideally, purified proteins should be used. 
Specific affinity of the M. tuberculosis antigens TB10.4 and HspX (TH) or the dendritic 
cell binding peptide sequence (DC-seq) for peptidoglycan is not known. Further 
experiments should be carried out to investigate whether binding of TH_DC-seq to L. 
plantarum WCFS1 was due to affinity toward the peptidoglycan layer or was due to affinity 
toward other components on the cell wall of L. plantarum WCFS1. Gram-positive enhancer 
matrix (GEM) particles could be used to test the peptidoglycan binding ability of both 
His3014_TH_DC-seq and TH_DC-seq. These are cells of Lactococcus lactis that are 
subjected to treatment that removes the intracellular content and results in GEM particles 
composing of peptidoglycan and the shape of lactococcal cells (Berlec et al., 2012). GEM 
particles could therefore also be considered for use in this study for another non-GM 
approach by anchoring antigens to GEM particle that are free of genetic materials.  
5.2 .Direct.display.of.M.#tuberculosis.antigens.on.the.cell.surface.of.L.#plantarum#
WCFS1.
In the GM-strategy, TH_DC-seq was coupled to three different anchors, which are 
derived from the genes of L. plantarum WCFS1 (section 1.5), and directly displayed on the 
cell surface of recombinant L. plantarum WCFS1. The three fusion proteins that were made 
in this study are 3014_TH_DC-seq (LysM-anchor), 1261_TH_DC-seq (lipobox-anchor) 
and 0373_TH_DC-seq_2578 (LPxTG-anchor) (see section 1.5, section 4.4.1 and Table 2.3 
for more details). In this case, the proteins are produced with an N-terminal signal peptide 
for protein secretion. Production of the proteins was confirmed by Western blot analysis 
using α-HspX with the exception of 0373_TH_DC-seq_2578 (Figure 4.19). The growth 
curve of L. plantarum WCFS1 carrying the plasmid pLp_0373_TH_DC-seq_2578 showed 
that upon induction, growth rate decreased rapidly or that growth even stopped (Appendix 
B, Figure B.2). This indicates that expressing pLp_0373_TH_DC-seq_2578 is stressful for 
L. plantarum WCFS1 which leads to cell death and, presumably, degradation of proteins.  
  DISCUSSION 
 
 91 
Attempts were made to detect anchor-coupled TH_DC-seq that was directly 
displayed on the cell surface of live recombinant L. plantarum WCFS1 using flow 
cytometry (data not shown). No positive signals were detected using the α-HspX as the 
primary antibody, thus successful cell surface display of TH_DC-seq through coupling to 
anchors was not confirmed. Flow cytometry analysis of TH_DC-seq (produced in E.coli 
from a pET-16b vector, section 4.3.1 and 5.1.1) gave positive signals using the same 
primary antibody and the same amount of cells. The lack of positive signals in flow 
cytometry analysis might therefore be due to expression with pLp vector and production in 
L. plantarum WCFS1, or that HspX-epitope seems not accessible for α-HspX when 
TH_DC-seq is coupled to an anchor. This might be due to steric hindrance caused by the 
folding of the proteins or that translocation of TH_DC-seq to the cell surface of L. 
plantarum WCFS1 was not complete.  
Fluorescence microscopy is another method that can detect antigens on the cell 
surface. But due to little time left for this study, no further experiments were conducted for 
the GM-strategy. 
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6 Conclusions.and.future.perspectives.
In this thesis, the production of the M. tuberculosis fusion antigen TB10.4-HspX in E. 
coli using a pET-16b vector and in L. plantarum WCFS1 using a pLp vector (a derivative 
of the pSIP system), has been described. TH was coupled to the dendritic cell binding 
peptide, FYPSYHSTPQRP (DC-seq), to promote targeting of dendritic cells in future 
immunologic experiments. TH_DC-seq was fused to anchors derived from proteins 
encoded in genes of L. plantarum WCFS1. The anchors used in this study are N-terminal 
LysM anchors derived from the genes lp_3014 and lp_2162, a N-terminal lipobox anchor 
derived from the gene lp_1261, and a C-terminal LPxTG anchor derived from the gene 
lp_2578.  
In the non-GM approaches, LysM coupled TB10.4-HspX_DC-seq was successfully 
produced intracellularly in E. coli and L. plantarum WCFS1, but the level of soluble 
proteins was low. There were also challenges met upon purification from extracts 
containing soluble proteins. Binding assays using the soluble fraction of protein extracts 
indicates that LysM-coupled TB10.4-HspX _DC-seq could bind to L. plantarum WCFS1, 
L. sakei Lb790 and L. rhamnosus GG. However, more detailed binding assays using L. 
plantarum WCFS1 only, also indicated that TB10.4-HspX _DC-seq without the LysM 
anchor also binds to L. plantarum WCFS1. Confirmation of the presence of TB10.4-HspX 
_DC-seq on the cell surface was not certain, as flow cytometry analysis was not successful. 
All in all, more experiments to investigate binding of TB10.4-HspX_DC-seq to the cell 
surface of Lactobacillus spp should be done to test the viability of the non-GM strategy. 
In the GM-strategy, TB10.4-HspX _DC-seq was fused with three different anchors to 
be directly displayed on the cell surface of recombinant L. plantarum WCFS1. The anchors 
used were a N-terminal LysM anchor, a N-terminal lipobox anchor and a C-terminal 
LPxTG anchor, all of which are derived from proteins encoded by genes of L. plantarum 
WCFS1. Production of anchor-coupled TB10.4-HspX _DC-seq was confirmed using 
Western blot analysis with the exception of TB10.4-HspX _DC-seq coupled to the LPxTG-
anchor. Confirmation of anchor-coupled TB10.4-HspX DC-seq displayed on the cell 
surface was not certain, as flow cytometry analysis was not successful. More experiments 
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to investigate the display of TB10.4-HspX_DC-seq on the cell surface should be done to 
test the viability of this GM-strategy.  
The main long term objective of this work is to develop an oral tuberculosis vaccine 
using lactobacilli as the delivery vehicle, and preferably by using a non-GM system for 
delivery, e.g. by binding the fusion antigens of M. tuberculosis to wild type L. plantarum 
WCFS1 that is regarded as safe to consume. Work done in this study shows that it is 
possible to produce TB10.4-HspX _DC-seq coupled to a LysM anchor intracellularly in 
both E. coli and L. plantarum WCFS1, and that both TB10.4-HspX _DC-seq with and 
without fusing to a LysM anchor are able to bind to L. plantarum WCFS1. The main 
challenges met in this study were the production of sufficient amount of soluble proteins 
and the purification of these minor amounts from protein extracts. Both expression and 
purification methods should be further investigated, as the fusion antigen TB10.4-HspX is a 
promising candidate as a multistage vaccine against tuberculosis. Thus, obtaining larger 
amount of pure TB10.4-HspX coupled to LysM domain is of high interest for use in 
experiments, especially with immunological experiments in mind for future work.  
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Appendix.A Extended.Material.List.
 
Software Supplier 
  
CLC Genomics Worckbench  CLC bio 
Serial Cloner 2.6.1 SerialBasics 
SnapGene® Viewer 2.7.1 GSL Biotech 
 
 
Material List for Laboratory Equipments Supplier 
  
BioPhotometer Eppendorf 
Cell density meter, Ultrospec 10  Biochrom 
Centrifuge; 5418R Eppendorf 
Centrifuge; Avanti™ J-25 Beckman Coulter 
Corex tube Corning Inc. 
Cryogenic screwcap tubes 2ml  Sarstedt 
Cuvette for spectrophotometry, 1.5 ml Brand 
Electroporation: 
- Gene Pulser®/Micropulser™ cuvettes, 0.2 cm 
- MicroPulser electroporator 
Bio-Rad 
Falcon 2059 Polypropylene Round-Bottom tubes Bacton Dickinson 
Magnetic stirrer IKA 
Millex-GP Syringe Filter Unit, 0.22 µm and 0.45 µm Merck Millipore 
pH meter Metrohm 
Syringe filter, 0.22 and 0.45 μm Millex-GP, Merck 
Millipore 
Vortex mixer, MS3 Basic IKA 
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Material List for Chemicals and Solution Supplier 
  
Acetic acid Merck KGaA 
Boric acid Merck KGaA 
Calcium chloride dihydrate Sigma-Aldrich 
D(+)-Glucose anhydrous VWR  
di-Sodium hydrogen phosphate dihydrate Merck KGaA 
Ethanol 96% Arcus 
Glycerol solution 85%  Merck KGaA 
Glycine Merck KGaA 
Magnesium chloride hexahydrate Merck KGaA 
Magnesium sulphate Sigma-Aldrich 
Polyethylen Glycol, PEG-1450 Sigma-Aldrich 
Potassium chloride Merck KGaA 
Potassium phosphate monobasic Sigma-Aldrich 
Sodium chloride  Merck KGaA 
Sodium hydroxide  Merck KGaA 
Sucrose Sigam-Aldrice 
Tris-HCL Sigma-Aldrich 
Tritriplex® III (EDTA) Merck KGaA 
Trizma®Base (Tris Base) Sigma-Aldrich 
Tween® 20 Sigma-Aldrich 
 
 
Material List for Agars, Media and Antibiotics Supplier 
  
Agar-agar Merck KGaA 
Ampicillin sodium salt Sigma-Aldrich 
Bacto™ Tryptone BD 
Bacto™ Yeast Extract BD 
Brain Heart Infusion broth  Oxoid™ 
                                                                                                                           APPENDIX 
 
 iii 
Erythromycin  Sigma-Aldrich 
MRS broth Oxoid™ 
 
 
Material List for Molecular Biological Materials  
Kits Supplier 
  
In-Fusion® HD Cloning Kit Clontech Laboratories 
JetStar™ 2.0 Plasmid Purification Kit Genomed 
NucleoSpin® Plasmid DNA Purification Macherey-Nagel GmbH & 
Co. KG   
NucleoSpin® Gel and PCR Clean-Up Macherey-Nagel GmbH & 
Co. KG   
Quick Ligation™ Kit New England Biolabs 
Mastercycler® gradient thermal cycler Eppendorf AG 
Qubit™ Fluorometer Invitrogen™  
  
Gel electrophoresis Supplier 
  
6X DNA Loading Dye Thermo Scientific 
Gel casting equipment 
- Gel caster 
- Gel tray 
Comb, 8 wells 
Bio-Rad 
GeneRuler™ 1kb DNA Ladder Thermo Scientific 
Mini-Sub cell GT cell Bio-Rad 
peqGREEN DNA and RNA Dye PEQLAB, VWR 
SeaKem® LE Agarose Lonza 
Supercoiled DNA Ladder New England Biolabs 
Quick-Load® 1kb DNA Ladder New England Biolabs 
Gel Doc™ EZ imaging system  Bio-Rad 
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PowerPac™ Basic Power Supply Bio-Rad 
UV Sample Tray  Bio-Rad 
 
 
Material List for Protein Expression and Extraction  
Protein expression Supplier 
  
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Sigma-Aldrich 
SppIP Sigma-Aldrich 
  
Cell disruption Supplier 
  
DNase  
FastPrep®-24 MP Biomedicals 
Tubes and lids for FastPrep®-24 Fisher Scientific 
Glass beads, acid washed, < 106 μm Sigma-Aldrich 
Lysozyme Sigma-Aldrich 
Imidazol 56748-250G Sigma-Aldrich 
PMSF (phenylmethylsulfonyl fluoride) Sigma-Aldrich 
Vibra-Cell VC750 Sonics & Materials 
  
Affinity chromatography Supplier 
  
BioLogic™ Low-Pressure Chromatography Systems Bio-Rad 
Columns for Low-Pressure systems Bio-Rad 
Protino® Ni-NTA Agarose Macherey-Nagel  
  
Protein analysis Supplier 
  
10% Mini-PROTEAN® TGX Stain-Free™ Precast Gels, 
10 wells 30 μl or 15 wells 15 μl 
Bio-Rad  
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10X Tris/Glycine/SDS Bio-Rad  
BenchMark™ Unstained Protein Ladder Novex® 
Gel Doc™ EZ imaging system Bio-Rad  
NuPAGE® LDS Sample Buffer (4X)  Invitrogen™ 
NuPAGE® Sample Reducing Agent (10X) Novex® 
Mini-PROTEAN Tetra Cell System, 4 gels Bio-Rad  
PowerPac™ 300 Bio-Rad  
Protein Assay 1X Dye Reagent Concentrate Bio-Rad 
Stain-Free Sample Tray  Bio-Rad  
  
Western blot Supplier 
  
Bovine serum albumin (BSA) VWR 
CL-Xposure™ Film Thermo Scientific  
Developer and fixative solutions Thermo Scientific  
iBlot® Dry Blotting System: 
- iBlot® Gel Transfer Device  
iBlot® Transfer Stacks Nitrocellulose Mini 
 
Life Technologies™ 
Novex® 
MagicMark™ XP Western Protein Standard Novex® 
Restore™ Plus Western Blot Stripping Buffer Thermo Scientific 
Skimmed Milk Powder VWR 
SuperSignal® West Pico Chemiluminescent Substrate Thermo Scientific 
SNAP i.d. 2.0 Protein Detection System - Mini Merck Millipore 
  
Flow cytometry Supplier 
  
MacsQuant® Analyzer Miltenyi Biotec 
MacsQuantify™ Software Miltenyi Biotec 
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Appendix.B Growth.curves.
 
 
Figure B.1 Growth curve of uninduced L. plantarum WCFS1 carrying pLp plasmid for production of anchor-
coupled TH_DC-seq at 30°C Overnight culture of all strains were diluted to OD600=0.1 and growth was measured hourly.  
 
 
Figure B.2 Growth curve of induced L. plantarum WCFS1 carrying pLp plasmid for production of anchor-coupled 
TH_DC-seq at 30°C Overnight culture of all strains were diluted to OD600=0.1 and growth was measured hourly. All 
strains were induced after two hours of incubation with 25 ng/ml SppIP. 
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Figure B.3 Growth curve of induced and uninduced L. plantarum WCFS1 carrying pLp_His3014_TH_DC-seq at 
30°C Overnight cultures of were diluted to OD600=0.1 and growth was measured hourly. The induced culture was induced 
after two hours of incubation with 25 ng/ml SppIP. 
 
 
 
 
Figure B.4 Growth curve of wild type L. plantarum WCFS1 and induced and uninduced L. plantarum WCFS1 
carrying pEV at 30°C Overnight cultures of were diluted to OD600=0.1 and growth was measured hourly. The induced 
culture was induced after two hours of incubation with 25 ng/ml SppIP. 
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